<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Identification of twelve new susceptibility loci for different histotypes of epithelial ovarian cancer</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2017-11-01">2017 November 01.</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">F</forename><surname>Damiola</surname></persName>
						</author>
						<author>
							<persName><forename type="first">F</forename><surname>Dao</surname></persName>
						</author>
						<author>
							<persName><roleName>L.D</roleName><forename type="first">M</forename><surname>Duran</surname></persName>
						</author>
						<author>
							<persName><roleName>B.D</roleName><forename type="first">M</forename><surname>DÃ¼rst</surname></persName>
						</author>
						<author>
							<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>-M</surname></persName>
						</author>
						<author>
							<persName><forename type="first">G</forename><surname>Giles</surname></persName>
						</author>
						<author>
							<persName><forename type="first">G</forename><surname>Glendon</surname></persName>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Kwong</surname></persName>
						</author>
						<author>
							<persName><forename type="first">D</forename><surname>Lambrechts</surname></persName>
						</author>
						<author>
							<persName><forename type="first">C</forename><surname>Lazaro</surname></persName>
						</author>
						<author>
							<persName><forename type="first">L</forename><surname>Lem</surname></persName>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Leminen</surname></persName>
						</author>
						<author>
							<persName><forename type="first">D</forename><surname>Leroux</surname></persName>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Lester</surname></persName>
						</author>
						<author>
							<persName><forename type="first">D</forename><surname>Liang</surname></persName>
						</author>
						<author>
							<persName><forename type="first">C</forename><surname>Liebrich</surname></persName>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Lilyquist</surname></persName>
						</author>
						<author>
							<persName><forename type="first">L</forename><surname>Lipworth</surname></persName>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Lissowska</surname></persName>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Lubi</surname></persName>
						</author>
						<author>
							<persName><forename type="first">L</forename><surname>Lundvall</surname></persName>
						</author>
						<author>
							<persName><forename type="first">S</forename><surname>Manoukian</surname></persName>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Mca</surname></persName>
						</author>
						<author>
							<persName><roleName>I.McN</roleName><forename type="first">J</forename><forename type="middle">R</forename><surname>Mcl</surname></persName>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Merritt</surname></persName>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Moffitt</surname></persName>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Montagna</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Peter</forename><surname>Maccallum</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Carl</forename><surname>Gustav</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">Departments of Oncology and Public Health and Primary Care</orgName>
								<orgName type="institution" key="instit1">PDPP</orgName>
								<orgName type="institution" key="instit2">University of Cambridge</orgName>
								<address>
									<settlement>Cambridge</settlement>
									<country key="GB">England</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department">Departments of Cancer Epidemiology and Gynecologic Oncology</orgName>
								<orgName type="institution">Moffitt Cancer Center</orgName>
								<address>
									<settlement>Tampa</settlement>
									<region>FL</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="institution" key="instit1">Wellcome Trust Sanger Institute</orgName>
								<orgName type="institution" key="instit2">Wellcome Genome Campus</orgName>
								<address>
									<postCode>CB10 1SA</postCode>
									<settlement>Hinxton, Cambridgeshire</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Centre for Cancer Genetic Epidemiology</orgName>
								<orgName type="department" key="dep2">Department of Public Health and Primary Care</orgName>
								<orgName type="laboratory">Strangeways Research Laboratory</orgName>
								<orgName type="institution">University of Cambridge</orgName>
								<address>
									<addrLine>Worts Causeway</addrLine>
									<settlement>Cambridge</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Department of Oncology</orgName>
								<orgName type="department" key="dep2">Centre for Cancer Genetic Epidemiology</orgName>
								<orgName type="institution">University of Phelan et al</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="laboratory">Strangeways Research Laboratory</orgName>
								<address>
									<settlement>Cambridge, Cambridge</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="department">Women&apos;s Cancer</orgName>
								<orgName type="institution">Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center</orgName>
								<address>
									<addrLine>8700 Beverly Boulevard, Suite 290W</addrLine>
									<settlement>Los Angeles</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff7">
								<orgName type="department" key="dep1">Department of Health Science Research</orgName>
								<orgName type="department" key="dep2">Division of Biomedical Statistics and Informatics</orgName>
								<orgName type="institution">Mayo Clinic</orgName>
								<address>
									<settlement>Rochester</settlement>
									<region>Minnesota</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff8">
								<orgName type="department">Department of Obstetrics and Gynecology</orgName>
								<orgName type="institution">Duke University Medical Center</orgName>
								<address>
									<settlement>Durham</settlement>
									<region>North Carolina</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff9">
								<orgName type="department">Department of Cancer Epidemiology</orgName>
								<orgName type="institution">Moffitt Cancer Center</orgName>
								<address>
									<settlement>Tampa</settlement>
									<region>FL</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff10">
								<orgName type="department" key="dep1">Department of Health Science Research</orgName>
								<orgName type="department" key="dep2">Division of Epidemiology</orgName>
								<orgName type="institution">Mayo Clinic</orgName>
								<address>
									<settlement>Rochester</settlement>
									<region>Minnesota</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff11">
								<orgName type="department" key="dep1">Center for Bioinformatics and Functional Genomics</orgName>
								<orgName type="department" key="dep2">Cedars-Sinai Medical Center</orgName>
								<orgName type="institution">Samuel Oschin Comprehensive Cancer Institute</orgName>
								<address>
									<settlement>Los Angeles</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff12">
								<orgName type="department">Department of Genetics and Computational Biology</orgName>
								<orgName type="institution">QIMR Berghofer Medical Research Institute</orgName>
								<address>
									<settlement>Brisbane</settlement>
									<region>QLD</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff13">
								<orgName type="department">Department of Public Health and Primary Care</orgName>
								<orgName type="laboratory">Centre for Cancer Genetic Epidemiology</orgName>
								<orgName type="institution">University of Cambridge</orgName>
								<address>
									<settlement>Cambridge</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff14">
								<orgName type="department">Genomics Center</orgName>
								<orgName type="institution" key="instit1">Centre Hospitalier Universitaire de QuÃ©bec Research Center</orgName>
								<orgName type="institution" key="instit2">Laval University</orgName>
								<address>
									<addrLine>2705 Laurier Boulevard</addrLine>
									<settlement>Quebec City</settlement>
									<region>Quebec</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff15">
								<orgName type="department">Department of Clinical Genetics</orgName>
								<orgName type="institution">Academic Medical Center</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff16">
								<orgName type="department">Department for Health Evidence</orgName>
								<orgName type="institution" key="instit1">Radboud university medical center</orgName>
								<orgName type="institution" key="instit2">Radboud Institute for Health Sciences</orgName>
								<address>
									<settlement>Nijmegen</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff17">
								<orgName type="institution">Netherlands Comprehensive Cancer Organisation</orgName>
								<address>
									<settlement>Utrecht</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff18">
								<orgName type="department">Center for Inherited Disease Research</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff19">
								<orgName type="department">Institute of Genetic Medicine</orgName>
								<orgName type="institution">Johns Hopkins University School of Medicine</orgName>
								<address>
									<postCode>21224</postCode>
									<settlement>Baltimore</settlement>
									<region>MD</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff20">
								<orgName type="institution" key="instit1">Yorkshire Regional Genetics Service</orgName>
								<orgName type="institution" key="instit2">Chapel Allerton Hospital</orgName>
								<address>
									<settlement>Leeds</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff21">
								<orgName type="department">Departments of Molecular Genetics and Laboratory Medicine and Pathobiology</orgName>
								<orgName type="institution" key="instit1">Lunenfeld-Tanenbaum Research Institute</orgName>
								<orgName type="institution" key="instit2">Mount Sinai Hospital</orgName>
								<address>
									<postCode>M5G 1X5</postCode>
									<settlement>Toronto</settlement>
									<region>Ontario</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff22">
								<orgName type="institution">University of Toronto</orgName>
								<address>
									<region>Ontario</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff23">
								<orgName type="department" key="dep1">Department of Epidemiology</orgName>
								<orgName type="department" key="dep2">Director of Genetic Epidemiology Research Institute</orgName>
								<orgName type="department" key="dep3">School of Medicine</orgName>
								<orgName type="institution">UCI Center for Cancer Genetics Research &amp; Prevention</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff24">
								<orgName type="institution">University of California Irvine</orgName>
								<address>
									<settlement>Irvine</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff25">
								<orgName type="institution">N.N. Alexandrov National Cancer Centre of Belarus</orgName>
								<address>
									<settlement>Minsk</settlement>
									<country key="BY">Belarus</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff26">
								<orgName type="institution">23 &quot;Agii Anargiri&quot; Cancer Hospital</orgName>
								<address>
									<settlement>Athens</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff27">
								<orgName type="department">Department of Gynaecology and Obstetrics</orgName>
								<orgName type="institution">University Hospital of Schleswig-Holstein</orgName>
								<address>
									<addrLine>Campus Kiel</addrLine>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff28">
								<orgName type="institution">Christian-Albrechts University Kiel</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff29">
								<orgName type="department">Department of Breast Medical Oncology and Clinical Cancer Genetics Program</orgName>
								<orgName type="institution">University Of Texas MD Andersson Cancer Center</orgName>
								<address>
									<addrLine>1515 Pressler Street, CBP 5</addrLine>
									<settlement>Houston</settlement>
									<region>TX</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff30">
								<orgName type="department">Department of Oncology and Pathology</orgName>
								<orgName type="institution">Karolinska University Hospital and Karolinska Institutet</orgName>
								<address>
									<settlement>Stockholm</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff31">
								<orgName type="department">Department of Preventive and Predictive Medicine</orgName>
								<orgName type="institution" key="instit1">Unit of Medical Genetics</orgName>
								<orgName type="institution" key="instit2">Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale Tumori (INT)</orgName>
								<address>
									<addrLine>Via Giacomo Venezian 1</addrLine>
									<postCode>20133</postCode>
									<settlement>Milan</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff32">
								<orgName type="department">Department of Medical Oncology</orgName>
								<orgName type="institution">University Hospital</orgName>
								<address>
									<addrLine>Vall d&apos;Hebron</addrLine>
									<settlement>Barcelona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff33">
								<orgName type="institution" key="instit1">Gynaecology Unit</orgName>
								<orgName type="institution" key="instit2">The Royal Marsden Hospital</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff34">
								<orgName type="institution" key="instit1">BÃ¢timent Cheney D</orgName>
								<orgName type="institution" key="instit2">Centre LÃ©on BÃ©rard</orgName>
								<address>
									<addrLine>28 rue LaÃ«nnec</addrLine>
									<settlement>Lyon</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff35">
								<orgName type="department">Department of Pathology</orgName>
								<orgName type="laboratory">Laboratory of Cell Biology</orgName>
								<orgName type="institution">Landspitali-LSH v/Hringbraut</orgName>
								<address>
									<addrLine>hus 9</addrLine>
									<postCode>101</postCode>
									<settlement>Reykjavik</settlement>
									<country key="IS">Iceland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff36">
								<orgName type="department">Faculty of Medicine</orgName>
								<orgName type="institution" key="instit1">BMC (Biomedical Centre)</orgName>
								<orgName type="institution" key="instit2">University of Iceland</orgName>
								<address>
									<addrLine>Vatnsmyrarvegi 16</addrLine>
									<postCode>101</postCode>
									<settlement>Reykjavik</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff37">
								<orgName type="department">Department of Gynecologic Oncology</orgName>
								<orgName type="institution">Oregon Health &amp; Science University</orgName>
								<address>
									<settlement>Portland</settlement>
									<region>OR</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff38">
								<orgName type="institution">Knight Cancer Institute</orgName>
								<address>
									<settlement>Portland</settlement>
									<region>OR</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff39">
								<orgName type="department">Department of Gynecology and Obstetrics</orgName>
								<orgName type="institution">Universtiy Hospital Erlangen</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff40">
								<orgName type="department">Comprehensive Cancer Center Erlangen Nuremberg</orgName>
								<orgName type="institution">Friedrich-Alexander-University Erlangen-Nuremberg</orgName>
								<address>
									<addrLine>Universitaetsstrasse 21-23</addrLine>
									<postCode>91054</postCode>
									<settlement>Erlangen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff41">
								<orgName type="department" key="dep1">Division of Epidemiology</orgName>
								<orgName type="department" key="dep2">Department of Medicine</orgName>
								<orgName type="department" key="dep3">Institute for Medicine and Public Health</orgName>
								<orgName type="institution">Vanderbilt University Medical Center</orgName>
								<address>
									<addrLine>Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center</addrLine>
									<settlement>Nashville</settlement>
									<region>TN</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff42">
								<orgName type="department">Human Genetics Group</orgName>
								<orgName type="laboratory">Spanish National Cancer Centre (CNIO), and Biomedical Network on Rare Diseases (CIBERER)</orgName>
								<address>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff43">
								<orgName type="department" key="dep1">Institute of Biochemistry and Genetics</orgName>
								<orgName type="department" key="dep2">Ufa Science Center</orgName>
								<orgName type="institution">Russian Academy of Sciences</orgName>
								<address>
									<settlement>Ufa, Bashkortostan</settlement>
									<country key="RU">Russia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff44">
								<orgName type="department" key="dep1">Division of Gynecologic Oncology</orgName>
								<orgName type="department" key="dep2">Princess Margaret Hospital</orgName>
								<orgName type="institution">University Health Network</orgName>
								<address>
									<settlement>Toronto</settlement>
									<region>Ontario</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff45">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">Massachusetts General Hospital</orgName>
								<address>
									<settlement>Boston</settlement>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff46">
								<orgName type="department">Department of Gynecology and Obstetrics</orgName>
								<orgName type="institution">Haukeland University Hospital</orgName>
								<address>
									<settlement>Bergen</settlement>
									<country key="NO">Norway</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff47">
								<orgName type="department">Department of Clinical Science</orgName>
								<orgName type="laboratory">Centre for Cancer Biomarkers</orgName>
								<orgName type="institution">University of Bergen</orgName>
								<address>
									<settlement>Bergen</settlement>
									<country key="NO">Norway</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff48">
								<orgName type="department">Division of Cancer Epidemiology and Genetics</orgName>
								<orgName type="institution">National Cancer Institute</orgName>
								<address>
									<settlement>Bethesda</settlement>
									<region>MD</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff49">
								<orgName type="department">Clinical Cancer Genetics</orgName>
								<orgName type="institution">City of Hope Clinical Cancer Genetics Community Research Network</orgName>
								<address>
									<settlement>Duarte</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff50">
								<orgName type="department">Department of Clinical Genetics</orgName>
								<orgName type="institution">Maastricht University Medical Center</orgName>
								<address>
									<settlement>Maastricht</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff51">
								<orgName type="laboratory">Radiation Oncology Research Unit</orgName>
								<orgName type="institution">Hannover Medical School</orgName>
								<address>
									<settlement>Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff52">
								<orgName type="department">Department of Clinical Genetics</orgName>
								<orgName type="institution">Vejle Hospital</orgName>
								<address>
									<settlement>Vejle</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff53">
								<orgName type="department" key="dep1">Division of Cancer Prevention and Genetics</orgName>
								<orgName type="department" key="dep2">Istituto Europeo di Oncologia (IEO)</orgName>
								<address>
									<addrLine>via Ripamonti 435</addrLine>
									<postCode>20141</postCode>
									<settlement>Milan</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff54">
								<orgName type="department" key="dep1">Department of Oncology</orgName>
								<orgName type="department" key="dep2">Clinical Sciences</orgName>
								<orgName type="institution">Lund University and SkÃ¥ne University Hospital</orgName>
								<address>
									<settlement>Lund</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff55">
								<orgName type="department" key="dep1">Department of Medicine</orgName>
								<orgName type="department" key="dep2">Abramson Cancer Center</orgName>
								<orgName type="department" key="dep3">Perelman School of Medicine</orgName>
								<orgName type="institution">The University of Pennsylvania</orgName>
								<address>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff56">
								<orgName type="institution" key="instit1">Cancer Research UK (CRUK) Cambridge Institute</orgName>
								<orgName type="institution" key="instit2">University of Cambridge</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff57">
								<orgName type="department">Department of Clinical Genetics</orgName>
								<orgName type="institution">Royal Devon and Exeter Hospital</orgName>
								<address>
									<settlement>Exeter</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff58">
								<orgName type="department">Department of Cancer Epidemiology</orgName>
								<orgName type="institution">University Hospital</orgName>
								<address>
									<settlement>Lund</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff59">
								<orgName type="institution">Lund University</orgName>
								<address>
									<settlement>Lund</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff60">
								<address>
									<country>Canada&apos;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff61">
								<orgName type="institution">Michael Smith Genome Sciences Centre, BC Cancer Agency</orgName>
								<address>
									<settlement>Vancouver</settlement>
									<region>BC</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff62">
								<orgName type="department">Cancer Epidemiology Centre</orgName>
								<address>
									<addrLine>Cancer Council Victoria</addrLine>
									<settlement>Melbourne</settlement>
									<region>VIC</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff63">
								<orgName type="department">IDIBGI (Institut d&apos;InvestigaciÃ³ BiomÃ¨dica de Girona)</orgName>
								<orgName type="laboratory">Genetic Counseling Unit, Hereditary Cancer Program</orgName>
								<orgName type="institution">Catalan Institute of Oncology. Av. FranÃ§a s/n</orgName>
								<address>
									<postCode>1707</postCode>
									<settlement>Girona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff64">
								<orgName type="department">Institut Curie</orgName>
								<orgName type="laboratory">Service de GÃ©nÃ©tique Oncologique</orgName>
								<address>
									<addrLine>26, rue d&apos;Ulm</addrLine>
									<postCode>Cedex 05</postCode>
									<settlement>Paris</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff65">
								<orgName type="department">Department of Pathology</orgName>
								<orgName type="institution">University of Helsinki and Helsinki University Hospital</orgName>
								<address>
									<settlement>Helsinki</settlement>
									<country key="FI">Finland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff66">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">Huntsman Cancer Institute</orgName>
								<address>
									<addrLine>2000 Circle of Hope</addrLine>
									<postCode>84112</postCode>
									<settlement>Salt Lake City</settlement>
									<region>UT</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff67">
								<orgName type="department">Molecular Oncology Laboratory</orgName>
								<orgName type="institution" key="instit1">Hospital Clinico San Carlos</orgName>
								<orgName type="institution" key="instit2">IdISSC (Instituto de InvestigaciÃ³n Sanitaria del Hospital ClÃ­nico San Carlos)</orgName>
								<address>
									<addrLine>Martin Lagos s/n</addrLine>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff68">
								<orgName type="department" key="dep1">Section of Genetic Oncology</orgName>
								<orgName type="department" key="dep2">Dept. of Laboratory Medicine</orgName>
								<orgName type="institution">University and University Hospital of Pisa</orgName>
								<address>
									<country>Pisa Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff69">
								<orgName type="department">Research Division</orgName>
								<orgName type="institution" key="instit1">Cancer Genetics Laboratory</orgName>
								<orgName type="institution" key="instit2">Peter MacCallum Cancer Centre</orgName>
								<address>
									<settlement>Melbourne</settlement>
									<region>VIC</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff70">
								<orgName type="department">Department of Pathology</orgName>
								<orgName type="institution">University of Melbourne</orgName>
								<address>
									<settlement>Parkville</settlement>
									<region>VIC</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff71">
								<orgName type="department">Cancer Pathology &amp; Prevention</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff72">
								<orgName type="department">Division of Cancer Prevention and Population Sciences</orgName>
								<orgName type="institution">Roswell Park Cancer Institute</orgName>
								<address>
									<settlement>Buffalo</settlement>
									<region>NY</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff73">
								<orgName type="department">Department of Obstetrics and Gynecology</orgName>
								<orgName type="institution" key="instit1">John A. Burns School of Medicine</orgName>
								<orgName type="institution" key="instit2">University of Hawaii</orgName>
								<address>
									<settlement>Honolulu</settlement>
									<region>Hawaii</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff74">
								<orgName type="institution">University of California</orgName>
								<address>
									<addrLine>1600 Divisadero Street</addrLine>
									<postCode>C415, 94143 -1714</postCode>
									<settlement>San Francisco, San Francisco</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff75">
								<orgName type="department" key="dep1">Division of Cancer Epidemiology</orgName>
								<orgName type="department" key="dep2">German Cancer Research Center (DKFZ)</orgName>
								<address>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff76">
								<orgName type="department">University Cancer Center Hamburg (UCCH)</orgName>
								<orgName type="institution">University Medical Center Hamburg-Eppendorf</orgName>
								<address>
									<settlement>Hamburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff77">
								<orgName type="department">Centre for Cancer Research</orgName>
								<orgName type="institution" key="instit1">The Westmead Institute for Medical Research</orgName>
								<orgName type="institution" key="instit2">The University of Sydney</orgName>
								<address>
									<settlement>Sydney</settlement>
									<region>New South Wales</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff78">
								<orgName type="department">Department of Gynaecological Oncology</orgName>
								<orgName type="institution">Westmead Hospital</orgName>
								<address>
									<settlement>Sydney</settlement>
									<region>New South Wales</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff79">
								<orgName type="department" key="dep1">Centre des Maladies du Sein DeschÃªnes-Fabia</orgName>
								<orgName type="department" key="dep2">Centre de Recherche</orgName>
								<orgName type="institution" key="instit1">UnitÃ© de Recherche en SantÃ© des Populations</orgName>
								<orgName type="institution" key="instit2">FRSQ du Centre Hospitalier AffiliÃ© Universitaire de QuÃ©bec</orgName>
								<address>
									<settlement>QuÃ©bec</settlement>
									<region>QC</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff80">
								<orgName type="department">Departments of Pediatrics and Medicine</orgName>
								<orgName type="institution">Columbia University</orgName>
								<address>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff81">
								<orgName type="department">Center for Medical Genetics</orgName>
								<orgName type="institution">Ghent University</orgName>
								<address>
									<settlement>Ghent</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff82">
								<orgName type="department">Division of Epidemiology, Biostatistics and Preventative Medicine</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff83">
								<orgName type="department">Department of Internal Medicine</orgName>
								<orgName type="institution">University of New Mexico</orgName>
								<address>
									<settlement>Albuquerque</settlement>
									<region>New Mexico</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff84">
								<orgName type="department">Sheffield Clinical Genetics Service</orgName>
								<orgName type="institution">Sheffield Children&apos;s Hospital</orgName>
								<address>
									<settlement>Sheffield</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff85">
								<orgName type="department" key="dep1">Obstetrics and Gynecology Epidemiology Center</orgName>
								<orgName type="department" key="dep2">Brigham and Women&apos;s Hospital</orgName>
								<orgName type="institution">Harvard Medical School</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff86">
								<orgName type="department" key="dep1">Department of Laboratory Medicine and Pathology</orgName>
								<orgName type="department" key="dep2">Division of Experimental Pathology</orgName>
								<orgName type="institution">Mayo Clinic</orgName>
								<address>
									<settlement>Rochester</settlement>
									<region>MN</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff87">
								<orgName type="institution">Social &amp; Scientific Systems, Inc. Durham</orgName>
								<address>
									<postCode>27703</postCode>
									<region>NC</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff88">
								<orgName type="department" key="dep1">Department of Clinical Genetics</orgName>
								<orgName type="department" key="dep2">Fox Chase Cancer Center</orgName>
								<address>
									<addrLine>333 Cottman Avenue</addrLine>
									<postCode>19111</postCode>
									<settlement>Philadelphia</settlement>
									<region>PA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff89">
								<orgName type="department">Department of Genetics and Fundamental Medicine</orgName>
								<orgName type="institution">Bashkir State University</orgName>
								<address>
									<settlement>Ufa</settlement>
									<country key="RU">Russia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff90">
								<orgName type="department" key="dep1">Department of Pathology and Laboratory Diagnostics</orgName>
								<orgName type="department" key="dep2">Institute of Oncology</orgName>
								<orgName type="department" key="dep3">81 Gynecology Service</orgName>
								<orgName type="department" key="dep4">Department of Surgery</orgName>
								<orgName type="institution">the Maria Sklodowska-Curie Memorial Cancer Center</orgName>
								<address>
									<settlement>Warsaw</settlement>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff91">
								<orgName type="institution">Memorial Sloan Kettering Cancer Center</orgName>
								<address>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff92">
								<orgName type="department">Department of Clinical Genetics</orgName>
								<orgName type="institution">South Glasgow University Hospitals</orgName>
								<address>
									<settlement>Glasgow</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff93">
								<orgName type="institution" key="instit1">UnitÃ© d&apos;oncogÃ©nÃ©tique</orgName>
								<orgName type="institution" key="instit2">ICO-Centre RenÃ© Gauducheau</orgName>
								<orgName type="institution" key="instit3">Boulevard Jacques Monod</orgName>
								<address>
									<postCode>44805</postCode>
									<settlement>Nantes Saint Herblain Cedex</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff94">
								<orgName type="institution" key="instit1">Oncogenetics Group</orgName>
								<orgName type="institution" key="instit2">Vall d&apos;Hebron Institute of Oncology (VHIO)</orgName>
								<address>
									<settlement>Barcelona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff95">
								<orgName type="department">Clinical and Molecular Genetics Area</orgName>
								<orgName type="institution">Vall d&apos;Hebron University Hospital</orgName>
								<address>
									<settlement>Barcelona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff96">
								<orgName type="department">Department of Population Sciences</orgName>
								<orgName type="institution">Beckman Research Institute of City of Hope</orgName>
								<address>
									<settlement>Duarte</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff97">
								<orgName type="department" key="dep1">Department of Epidemiology</orgName>
								<orgName type="department" key="dep2">The Geisel School of Medicine -at Dartmouth</orgName>
								<address>
									<settlement>Hanover</settlement>
									<region>New Hampshire</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff98">
								<orgName type="department">Department of Genetics</orgName>
								<orgName type="laboratory">Cancer Genetics Laboratory</orgName>
								<orgName type="institution">University of Pretoria</orgName>
								<address>
									<settlement>Pretoria</settlement>
									<country key="ZA">South Africa</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff99">
								<orgName type="laboratory">Gynaecology Research Unit</orgName>
								<orgName type="institution">Hannover Medical School</orgName>
								<address>
									<settlement>Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff100">
								<orgName type="department" key="dep1">Nutrition and Metabolism Section</orgName>
								<orgName type="department" key="dep2">International Agency for Research on Cancer (IARC-WHO)</orgName>
								<address>
									<settlement>Lyon</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff101">
								<orgName type="department">Institute of Biology and Molecular Genetics</orgName>
								<orgName type="institution">Universidad de Valladolid (IBGM-UVA)</orgName>
								<address>
									<settlement>Valladolid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff102">
								<orgName type="department">Department of Gynecology</orgName>
								<orgName type="institution">Jena University Hospital -Friedrich Schiller University</orgName>
								<address>
									<settlement>Jena</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff103">
								<orgName type="department">Institute of Human Genetics</orgName>
								<address>
									<settlement>MÃ¼nster</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff104">
								<orgName type="department">Faculty of Medicine</orgName>
								<orgName type="institution" key="instit1">University of Southampton</orgName>
								<orgName type="institution" key="instit2">Southampton University Hospitals NHS Trust</orgName>
								<address>
									<settlement>Southampton</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff105">
								<orgName type="institution" key="instit1">Oncogenetics Team</orgName>
								<orgName type="institution" key="instit2">The Institute of Cancer Research and Royal Marsden NHS Foundation Trust</orgName>
								<address>
									<settlement>Sutton</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff106">
								<orgName type="department">Department of Oncology, Rigshospitalet</orgName>
								<orgName type="institution">Copenhagen University Hospital</orgName>
								<address>
									<settlement>Copenhagen</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff107">
								<orgName type="department">Institute of Human Genetics</orgName>
								<orgName type="institution">Friedrich-Alexander-University Erlangen-Nuremberg</orgName>
								<address>
									<settlement>Erlangen</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff108">
								<orgName type="department">Department of Biostatistics &amp; Bioinformatics</orgName>
								<orgName type="institution">Roswell park Institute</orgName>
								<address>
									<settlement>Buffalo</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff109">
								<orgName type="department">Institute for Medical Informatics, Statistics and Epidemiology</orgName>
								<orgName type="institution">University of Leipzig</orgName>
								<address>
									<settlement>Leipzig</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff110">
								<orgName type="department">Genomic Medicine</orgName>
								<orgName type="institution" key="instit1">Manchester Academic Health Sciences Centre</orgName>
								<orgName type="institution" key="instit2">University of Manchester</orgName>
								<orgName type="institution" key="instit3">Central Manchester University Hospitals NHS Foundation Trust</orgName>
								<address>
									<settlement>Manchester</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff111">
								<orgName type="department" key="dep1">David Geffen School of Medicine</orgName>
								<orgName type="department" key="dep2">Department of Medicine</orgName>
								<orgName type="department" key="dep3">Division of Hematology and Oncology</orgName>
								<orgName type="institution">University of California at Los Angeles</orgName>
								<address>
									<settlement>Los Angeles</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff112">
								<orgName type="laboratory">Laboratoire de GÃ©nÃ©tique Chromosomique</orgName>
								<orgName type="institution">HÃ´tel Dieu Centre Hospitalier</orgName>
								<address>
									<settlement>ChambÃ©ry</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff113">
								<orgName type="department">Department of Surgery and Cancer</orgName>
								<orgName type="institution">Imperial College London</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff114">
								<orgName type="department">Molecular Diagnostics Laboratory</orgName>
								<orgName type="institution">INRASTES</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff115">
								<orgName type="institution" key="instit1">National Centre for Scientific Research &quot;Demokritos&quot;</orgName>
								<orgName type="institution" key="instit2">Aghia Paraskevi Attikis</orgName>
								<address>
									<settlement>Athens</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff116">
								<orgName type="department">Departments of Human Genetics and Oncology</orgName>
								<orgName type="laboratory">Program in Cancer Genetics</orgName>
								<orgName type="institution">McGill University</orgName>
								<address>
									<settlement>Montreal</settlement>
									<region>Quebec</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff117">
								<orgName type="department">Department of Medical Oncology</orgName>
								<orgName type="institution">Aristotle University of Thessaloniki School of Medicine</orgName>
								<address>
									<settlement>Papageorgiou, Thessaloniki</settlement>
									<region>Hospital</region>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff118">
								<orgName type="department" key="dep1">Biostatistics and Informatics Shared Resource</orgName>
								<orgName type="department" key="dep2">Medical Center</orgName>
								<orgName type="institution">University of Kansas</orgName>
								<address>
									<settlement>Kansas City</settlement>
									<region>KS</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff119">
								<orgName type="institution">Harvard TH Chan School of Public Health and Dana Farber Cancer Institute</orgName>
								<address>
									<addrLine>450 Brookline Ave</addrLine>
									<postCode>1101, 02215</postCode>
									<settlement>Dana Building, Boston</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff120">
								<orgName type="department" key="dep1">Institute of Human Genetics</orgName>
								<orgName type="department" key="dep2">Sackler Faculty of Medicine</orgName>
								<orgName type="institution" key="instit1">The Susanne Levy Gertner Oncogenetics Unit</orgName>
								<orgName type="institution" key="instit2">Chaim Sheba Medical Center</orgName>
								<address>
									<settlement>Ramat Gan 52621</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff121">
								<orgName type="institution">Tel Aviv University</orgName>
								<address>
									<postCode>69978</postCode>
									<settlement>Ramat Aviv</settlement>
									<country key="IL">Israel</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff122">
								<orgName type="department" key="dep1">Division of Cancer Prevention and Control Research</orgName>
								<orgName type="department" key="dep2">Jonsson Comprehensive Cancer Center</orgName>
								<orgName type="institution">UCLA Schools of Medicine and Public Health</orgName>
								<address>
									<settlement>Los Angeles</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff123">
								<orgName type="department">Dana Farber Cancer Institute</orgName>
								<orgName type="institution">Cancer Risk and Prevention Clinic</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff124">
								<orgName type="department">Centre of Familial Breast and Ovarian Cancer</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff125">
								<orgName type="department" key="dep1">Department of Medical Genetics</orgName>
								<orgName type="department" key="dep2">Institute of Human Genetics</orgName>
								<orgName type="institution">University WÃ¼rzburg</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff126">
								<orgName type="department" key="dep1">113 Women&apos;s Cancer</orgName>
								<orgName type="department" key="dep2">Institute for Women&apos;s Health</orgName>
								<orgName type="institution">University College London</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff127">
								<orgName type="department">Department of Clinical Genetics</orgName>
								<orgName type="institution">Copenhagen University Hospital</orgName>
								<address>
									<settlement>Rigshospitalet, Copenhagen</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff128">
								<orgName type="department">School of Population and Global Health</orgName>
								<orgName type="laboratory">Centre for Epidemiology and Biostatistics</orgName>
								<orgName type="institution">University of Melbourne</orgName>
								<address>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff129">
								<orgName type="department">Department of Epidemiology and Preventive Medicine</orgName>
								<orgName type="institution">Monash University</orgName>
								<address>
									<settlement>Melbourne</settlement>
									<region>VIC</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff130">
								<orgName type="institution">The Beatson West of Scotland Cancer Centre</orgName>
								<address>
									<settlement>Glasgow</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff131">
								<orgName type="department">Department of Pathology and Laboratory Medicine</orgName>
								<orgName type="institution" key="instit1">Ontario Cancer Genetics Network: Samuel Lunenfeld Research Institute</orgName>
								<orgName type="institution" key="instit2">Mount Sinai Hospital</orgName>
								<address>
									<postCode>M5G 1X5 119</postCode>
									<settlement>Toronto</settlement>
									<region>Ontario</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff132">
								<orgName type="department">Medical Center</orgName>
								<orgName type="institution">University of Kansas</orgName>
								<address>
									<settlement>Kansas City</settlement>
									<region>KS</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff133">
								<orgName type="department">Department of Dermatology</orgName>
								<orgName type="institution">University of Utah School of Medicine</orgName>
								<address>
									<settlement>Salt Lake City, Utah</settlement>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff134">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">Royal Marsden Hospital</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff135">
								<orgName type="department" key="dep1">Clinical Genetics Branch</orgName>
								<orgName type="department" key="dep2">DCEG</orgName>
								<orgName type="department" key="dep3">Medical Center Drive</orgName>
								<orgName type="institution">NCI</orgName>
								<address>
									<postCode>9609, 6E-454</postCode>
									<settlement>Room, Bethesda</settlement>
									<region>NIH, MD</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff136">
								<orgName type="department">Department of Genetics and Pathology</orgName>
								<orgName type="institution">Pomeranian Medical University</orgName>
								<address>
									<settlement>Szczecin</settlement>
									<country>Poland 124 Keck</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff137">
								<orgName type="department">School of Medicine, and Norris Comprehensive Cancer Center</orgName>
								<orgName type="institution">University of Southern California</orgName>
								<address>
									<settlement>Los Angeles</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff138">
								<orgName type="department" key="dep1">CA 125 Center for Familial Breast and Ovarian Cancer</orgName>
								<orgName type="department" key="dep2">Center for Integrated Oncology (CIO) and Center for Molecular Medicine Phelan et al</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff139">
								<orgName type="department">Cologne (CMMC)</orgName>
								<orgName type="institution">University Hospital Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff140">
								<orgName type="department" key="dep1">Department of Preventive Medicine</orgName>
								<orgName type="department" key="dep2">Keck School of Medicine</orgName>
								<orgName type="institution">University of Southern California Norris Comprehensive Cancer Center</orgName>
								<address>
									<settlement>Los Angeles</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff141">
								<orgName type="department" key="dep1">Department of Environmental Medicine</orgName>
								<orgName type="department" key="dep2">Division of Nutritional Epidemiology</orgName>
								<orgName type="department" key="dep3">128 Molecular Genetics of Breast Cancer</orgName>
								<orgName type="department" key="dep4">Deutsches Krebsforschungszentrum (DKFZ)</orgName>
								<orgName type="institution">Karolinska Institutet</orgName>
								<address>
									<postCode>SE-171 77</postCode>
									<settlement>STOCKHOLM, Heidelberg</settlement>
									<country>Sweden, Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff142">
								<orgName type="department">Center for Genomic Medicine</orgName>
								<orgName type="institution">Copenhagen University Hospital</orgName>
								<address>
									<settlement>Rigshospitalet, Copenhagen</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff143">
								<orgName type="department" key="dep1">Institute of Genetic Medicine</orgName>
								<orgName type="department" key="dep2">Centre for Life</orgName>
								<orgName type="institution">Newcastle Upon Tyne Hospitals NHS Trust</orgName>
								<address>
									<settlement>Newcastle upon Tyne</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff144">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution">The University of Texas MD Anderson Cancer Center</orgName>
								<address>
									<settlement>Houston</settlement>
									<region>TX</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff145">
								<orgName type="department" key="dep1">Clinics of Obstetrics and Gynaecology</orgName>
								<orgName type="department" key="dep2">Hannover Medical School</orgName>
								<address>
									<settlement>Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff146">
								<orgName type="department">Medical Genetics Unit</orgName>
								<orgName type="institution">University of London</orgName>
								<address>
									<settlement>St George&apos;s</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff147">
								<orgName type="department">Department of Gynecology, Rigshospitalet</orgName>
								<orgName type="institution">University of Copenhagen</orgName>
								<address>
									<settlement>Copenhagen</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff148">
								<orgName type="department" key="dep1">Department of Virus, Lifestyle and Genes</orgName>
								<orgName type="department" key="dep2">Danish Cancer Society Research Center</orgName>
								<address>
									<addrLine>136 Molecular Unit</addrLine>
									<settlement>Copenhagen</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff149">
								<orgName type="department">Department of Pathology</orgName>
								<orgName type="institution" key="instit1">Herlev Hospital</orgName>
								<orgName type="institution" key="instit2">University of Copenhagen</orgName>
								<address>
									<addrLine>137 Family Cancer Clinic</addrLine>
									<settlement>Copenhagen</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff150">
								<orgName type="institution">Netherlands Cancer Institute</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff151">
								<orgName type="department" key="dep1">Department of Medical Oncology</orgName>
								<orgName type="department" key="dep2">Family Cancer Clinic</orgName>
								<orgName type="institution">Erasmus University Medical Center</orgName>
								<address>
									<addrLine>The Netherlands 139 Center For Immunotherapy</addrLine>
									<settlement>Rotterdam</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff152">
								<orgName type="institution">Roswell Park Cancer Institute</orgName>
								<address>
									<settlement>Buffalo</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff153">
								<orgName type="department">Center for Medical Genetics</orgName>
								<orgName type="institution" key="instit1">NorthShore University HealthSystem</orgName>
								<orgName type="institution" key="instit2">University of Chicago Pritzker School of Medicine</orgName>
								<address>
									<addrLine>1000 Central Street, Suite 620</addrLine>
									<postCode>60201</postCode>
									<settlement>Evanston</settlement>
									<region>IL</region>
									<country>US</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff154">
								<orgName type="department" key="dep1">Program in Genetic Epidemiology and Statistical Genetics</orgName>
								<orgName type="department" key="dep2">Department of Epidemiology</orgName>
								<orgName type="institution">The Harvard T.H. Chan School of Public Health</orgName>
								<address>
									<addrLine>677 Huntington Avenue</addrLine>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff155">
								<orgName type="department">Departments of Pathology and Laboratory Medicine</orgName>
								<orgName type="institution" key="instit1">British Columbia&apos;s Ovarian Cancer Research (OVCARE) Program</orgName>
								<orgName type="institution" key="instit2">Vancouver General Hospital</orgName>
								<orgName type="institution" key="instit3">BC Cancer Agency and University of British Columbia</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff156">
								<orgName type="department">Obstetrics and Gynaecology and Molecular Oncology</orgName>
								<address>
									<settlement>Vancouver</settlement>
									<region>British Columbia</region>
									<country key="CA">CANADA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff157">
								<orgName type="department">143 N.N. Petrov Institute of Oncology</orgName>
								<address>
									<settlement>St.Petersburg</settlement>
									<country key="RU">Russia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff158">
								<orgName type="laboratory">Lombardi Comprehensive Cancer Center</orgName>
								<orgName type="institution">Georgetown University</orgName>
								<address>
									<addrLine>3800 Reservoir Road NW</addrLine>
									<settlement>Washington</settlement>
									<region>DC</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff159">
								<orgName type="department">Department of Statistical Science</orgName>
								<orgName type="institution">Duke University</orgName>
								<address>
									<settlement>Durham</settlement>
									<region>North Carolina</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff160">
								<orgName type="department">Clinical Genetics</orgName>
								<orgName type="institution">Thomas&apos; NHS Foundation Trust</orgName>
								<address>
									<addrLine>Guy&apos;s and St</addrLine>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff161">
								<orgName type="department" key="dep1">Familial Cancer Centre</orgName>
								<orgName type="department" key="dep2">Peter MacCallum Cancer Centre</orgName>
								<address>
									<addrLine>Locked Bag 1, A&apos;Beckett Street</addrLine>
									<postCode>8006</postCode>
									<settlement>Melbourne</settlement>
									<region>VIC</region>
									<country>AUSTRALIA; Sir</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff162">
								<orgName type="department">Dept of Oncology</orgName>
								<orgName type="institution">University of Melbourne</orgName>
								<address>
									<postCode>3010 148</postCode>
									<settlement>VIC</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff163">
								<orgName type="department" key="dep1">Hematology, Oncology and Transfusion Medicine Center</orgName>
								<orgName type="department" key="dep2">Department of Molecular and Regenerative Medicine</orgName>
								<orgName type="department" key="dep3">149 State Research Institute Centre for Innovative Medicine</orgName>
								<orgName type="institution">Vilnius University Hospital Santariskiu Clinics</orgName>
								<address>
									<settlement>Vilnius, Vilnius</settlement>
									<country>Lithuania, Lithuania</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff164">
								<orgName type="department">Department of Obstetrics and Gynecology</orgName>
								<orgName type="institution">Lund University Hospital</orgName>
								<address>
									<settlement>Lund</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff165">
								<orgName type="department">Department of Clinical Genetics</orgName>
								<orgName type="institution">Aarhus University Hospital</orgName>
								<address>
									<addrLine>Brendstrupgaardsvej 21C, Aarhus N</addrLine>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff166">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution">Cancer Prevention Institute of California</orgName>
								<address>
									<settlement>Fremont</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff167">
								<orgName type="department" key="dep1">Division of Genetics and Epidemiology</orgName>
								<orgName type="department" key="dep2">Institute of Cancer Research</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff168">
								<orgName type="department">Department of Gynaecology and Obstetrics</orgName>
								<orgName type="institution">University Hospital</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff169">
								<orgName type="institution">Technical University</orgName>
								<address>
									<settlement>Carus, Dresden</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff170">
								<orgName type="department">Department of Obstetrics and Gynecology</orgName>
								<orgName type="institution">University of Helsinki and Helsinki University Central Hospital</orgName>
								<address>
									<settlement>Helsinki</settlement>
									<region>HUS</region>
									<country key="FI">Finland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff171">
								<orgName type="department" key="dep1">Department of Surgery</orgName>
								<orgName type="department" key="dep2">Breast Care Center</orgName>
								<orgName type="institution">Daerim St. Mary&apos;s Hospital</orgName>
								<address>
									<addrLine>657 Siheung-daero, Yeongdeungpo-gu</addrLine>
									<postCode>150-822</postCode>
									<settlement>Seoul</settlement>
									<country key="KR">Korea</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff172">
								<orgName type="department">Department of Pathology</orgName>
								<orgName type="institution">University of Calgary</orgName>
								<address>
									<settlement>Calgary</settlement>
									<region>Alberta</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff173">
								<orgName type="department">Department of Clinical Genetics</orgName>
								<orgName type="institution">Odense University Hospital</orgName>
								<address>
									<addrLine>Odense C</addrLine>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff174">
								<orgName type="department">Department of Surgery</orgName>
								<orgName type="institution">The Hong Kong Hereditary Breast Cancer Family Registry</orgName>
								<address>
									<postCode>160</postCode>
									<settlement>Hong Kong</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff175">
								<orgName type="department" key="dep1">Cancer Genetics Center</orgName>
								<orgName type="department" key="dep2">Department of Surgery</orgName>
								<orgName type="institution">The University of Hong Kong</orgName>
								<address>
									<settlement>Hong Kong 161</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff176">
								<orgName type="institution">Hong Kong Sanatorium and Hospital</orgName>
								<address>
									<addrLine>162 Vesalius Research Center</addrLine>
									<settlement>Hong Kong</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff177">
								<orgName type="institution">VIB</orgName>
								<address>
									<settlement>Leuven</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff178">
								<orgName type="department">Department of Oncology</orgName>
								<orgName type="laboratory">Laboratory for Translational Genetics</orgName>
								<address>
									<settlement>KULeuven</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff179">
								<orgName type="department">CIBER of Epidemiology and Public Health (CIBERESP)</orgName>
								<orgName type="institution" key="instit1">Public Health Division of Gipuzkoa</orgName>
								<orgName type="institution" key="instit2">Regional Government of the Basque Country</orgName>
								<address>
									<postCode>165</postCode>
									<country>Spain, Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff180">
								<orgName type="institution">166 Molecular Diagnostic Unit</orgName>
								<address>
									<addrLine>Hereditary Cancer Program</addrLine>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff181">
								<orgName type="institution">IDIBELL-Catalan Institute of Oncology</orgName>
								<address>
									<settlement>Barcelona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff182">
								<orgName type="department">168 Cancer Epidemiology Program</orgName>
								<orgName type="institution" key="instit1">Cancer Control Research</orgName>
								<orgName type="institution" key="instit2">BC Cancer Agency</orgName>
								<address>
									<settlement>Vancouver</settlement>
									<region>BC</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff183">
								<orgName type="institution">University of Hawaii Cancer Center</orgName>
								<address>
									<settlement>Hawaii</settlement>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff184">
								<orgName type="department">Department of Surgery</orgName>
								<orgName type="institution">Ulsan College of Medicine and Asan Medical Center</orgName>
								<address>
									<settlement>Seoul</settlement>
									<country key="KR">Korea</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff185">
								<orgName type="department">Department of Gynecological Oncology</orgName>
								<orgName type="institution">Roswell Park Cancer Institute</orgName>
								<address>
									<settlement>Buffalo</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff186">
								<orgName type="department" key="dep1">DÃ©partement de GÃ©nÃ©tique</orgName>
								<orgName type="department" key="dep2">Institut Curie</orgName>
								<orgName type="institution">Centre Hospitalier Universitaire de Grenoble</orgName>
								<address>
									<addrLine>BP 217</addrLine>
									<postCode>172</postCode>
									<settlement>Grenoble Cedex 9</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff187">
								<orgName type="institution">PSL Research Unviersity and Inserm</orgName>
								<address>
									<postCode>U900</postCode>
									<settlement>Paris</settlement>
									<region>Mines</region>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff188">
								<orgName type="institution">Paris Tech</orgName>
								<address>
									<settlement>Fontainebleau</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff189">
								<orgName type="department">College of Pharmacy and Health Sciences</orgName>
								<orgName type="institution">Texas Southern University</orgName>
								<address>
									<settlement>Houston</settlement>
									<region>Texas</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff190">
								<orgName type="department" key="dep1">Cancer Center Wolfsburg</orgName>
								<orgName type="department" key="dep2">Clinics of Gynaecology</orgName>
								<address>
									<settlement>Wolfsburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff191">
								<orgName type="department">Department of Health Sciences Research</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff192">
								<orgName type="department">Division of Epidemiology</orgName>
								<orgName type="institution">Mayo Clinic</orgName>
								<address>
									<settlement>Rochester</settlement>
									<region>MN</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff193">
								<orgName type="department" key="dep1">Division of Epidemiology</orgName>
								<orgName type="department" key="dep2">Department of Medicine</orgName>
								<orgName type="department" key="dep3">Vanderbilt Epidemiology Center and Vanderbilt-Ingram Cancer Center</orgName>
								<orgName type="institution">Vanderbilt University School of Medicine</orgName>
								<address>
									<settlement>Nashville</settlement>
									<region>TN</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff194">
								<orgName type="department" key="dep1">Department of Cancer Epidemiology and Prevention</orgName>
								<orgName type="department" key="dep2">Institute of Oncology</orgName>
								<orgName type="institution">Maria Sklodowska-Curie Memorial Cancer Center</orgName>
								<address>
									<settlement>Warsaw</settlement>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff195">
								<orgName type="department">Department of Gynecologic Oncology</orgName>
								<orgName type="institution">The University of Texas MD Anderson Cancer Center</orgName>
								<address>
									<settlement>Houston</settlement>
									<region>TX</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff196">
								<orgName type="department">Department of Gynecology, Rigshospitalet</orgName>
								<orgName type="institution" key="instit1">The Juliane Marie Centre</orgName>
								<orgName type="institution" key="instit2">University of Copenhagen</orgName>
								<address>
									<addrLine>180 INSERM U1052</addrLine>
									<settlement>Copenhagen</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff197">
								<orgName type="department" key="dep1">Centre de Recherche en CancÃ©rologie de Lyon</orgName>
								<orgName type="department" key="dep2">Centre LÃ©on BÃ©rard</orgName>
								<orgName type="institution" key="instit1">CNRS UMR5286</orgName>
								<orgName type="institution" key="instit2">UniversitÃ© Lyon 1</orgName>
								<address>
									<settlement>Lyon</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff198">
								<orgName type="institution">Ovarian Cancer Research (OVCARE) Program -Gynecologic Tissue Bank</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff199">
								<orgName type="institution">Vancouver General Hospital and BC Cancer Agency</orgName>
								<address>
									<settlement>Vancouver</settlement>
									<region>British Columbia CANADA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff200">
								<orgName type="department">Department of Health Research and Policy -Epidemiology</orgName>
								<orgName type="institution">Stanford University School of Medicine</orgName>
								<address>
									<settlement>Stanford</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff201">
								<orgName type="institution">Public Health Ontario</orgName>
								<address>
									<settlement>Toronto</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff202">
								<orgName type="department">Institute of Cancer Sciences</orgName>
								<orgName type="institution" key="instit1">University of Glasgow</orgName>
								<orgName type="institution" key="instit2">Wolfson Wohl Cancer Research Centre</orgName>
								<orgName type="institution" key="instit3">Beatson Institute for Cancer Research</orgName>
								<address>
									<settlement>Glasgow</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff203">
								<orgName type="department">Department of Clinical Genetics</orgName>
								<orgName type="institution">VU University Medical Centre</orgName>
								<address>
									<postBox>P.O. Box 7057</postBox>
									<postCode>1007 MB</postCode>
									<settlement>Amsterdam</settlement>
									<country key="NL">the Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff204">
								<orgName type="department" key="dep1">Department of Gynaecology and Obstetrics</orgName>
								<orgName type="department" key="dep2">Division of Tumor Genetics</orgName>
								<orgName type="laboratory">Klinikum rechts der Isar</orgName>
								<orgName type="institution">Technical University of Munich</orgName>
								<address>
									<settlement>Munich</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff205">
								<orgName type="department">Department of Human Genetics</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff206">
								<orgName type="department">Phelan et al</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff207">
								<orgName type="institution">Radboud University Medical Centre</orgName>
								<address>
									<settlement>Nijmegen</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff208">
								<orgName type="department" key="dep1">Department of Epidemiology and Biostatistics</orgName>
								<orgName type="department" key="dep2">School of Public Health</orgName>
								<orgName type="institution">Imperial College London</orgName>
								<address>
									<postCode>W2 1PG</postCode>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff209">
								<orgName type="department">Sir Peter MacCallum Department of Oncology</orgName>
								<orgName type="institution">University of Melbourne</orgName>
								<address>
									<settlement>Parkville</settlement>
									<region>VIC</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff210">
								<orgName type="department">Division of Gynecologic Oncology</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff211">
								<orgName type="department">Department of Obstetrics, Gynecology and Reproductive Sciences</orgName>
								<orgName type="institution">University of Pittsburgh School of Medicine</orgName>
								<address>
									<settlement>Pittsburgh</settlement>
									<region>Pennsylvania</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff212">
								<orgName type="department" key="dep1">Department of Epidemiology</orgName>
								<orgName type="department" key="dep2">Graduate School of Public Health</orgName>
								<orgName type="institution">University of Pittsburgh</orgName>
								<address>
									<settlement>Pittsburgh</settlement>
									<region>Pennsylvania</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff213">
								<orgName type="department">Ovarian Cancer Center of Excellence</orgName>
								<orgName type="institution" key="instit1">Womens Cancer Research Program</orgName>
								<orgName type="institution" key="instit2">Magee-Womens Research Institute and University of Pittsburgh Cancer Institute</orgName>
								<address>
									<settlement>Pittsburgh</settlement>
									<region>Pennsylvania</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff214">
								<orgName type="department">Department of Obstetrics and Gynecology</orgName>
								<orgName type="institution">Oregon Health and Science University</orgName>
								<address>
									<settlement>Portland</settlement>
									<region>OR</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff215">
								<orgName type="institution" key="instit1">Knight Cancer Institute</orgName>
								<orgName type="institution" key="instit2">Oregon Health &amp; Science University</orgName>
								<address>
									<settlement>Portland</settlement>
									<region>Oregon</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff216">
								<orgName type="department">Immunology and Molecular Oncology Unit</orgName>
								<orgName type="institution">Veneto Institute of Oncology IOV -IRCCS</orgName>
								<address>
									<addrLine>Via Gattamelata 64</addrLine>
									<settlement>Padua</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff217">
								<orgName type="department">Department of Laboratory Medicine and Pathobiology</orgName>
								<orgName type="institution">University of Toronto</orgName>
								<address>
									<settlement>Toronto</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff218">
								<orgName type="department">Department of Laboratory Medicine</orgName>
								<orgName type="institution" key="instit1">Keenan Research Centre of the Li Ka Shing Knowledge Institute</orgName>
								<orgName type="institution" key="instit2">St Michael&apos;s Hospital</orgName>
								<address>
									<settlement>Toronto</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff219">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="laboratory">Clinical Genetics Research Laboratory</orgName>
								<orgName type="institution">Memorial Sloan Kettering Cancer Center</orgName>
								<address>
									<addrLine>1275 York Avenue</addrLine>
									<postCode>10044</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff220">
								<orgName type="department">Department of Pathology, Rigshospitalet</orgName>
								<orgName type="institution">University of Copenhagen</orgName>
								<address>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff221">
								<orgName type="institution">The University of Texas School of Public Health</orgName>
								<address>
									<settlement>Houston</settlement>
									<region>TX</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff222">
								<orgName type="department">Department of Gynaecology and Obstetrics</orgName>
								<orgName type="institution" key="instit1">University Hospital DÃ¼sseldorf</orgName>
								<orgName type="institution" key="instit2">Heinrich-Heine University</orgName>
								<address>
									<settlement>DÃ¼sseldorf</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff223">
								<orgName type="institution" key="instit1">Invitae Corporation</orgName>
								<orgName type="institution" key="instit2">University of Southern California</orgName>
								<address>
									<addrLine>513 Parnassus Ave</addrLine>
									<settlement>San Francisco</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff224">
								<orgName type="department">Department of Molecular Genetics</orgName>
								<orgName type="institution">HSE 901E</orgName>
								<address>
									<postCode>94143 -0794 203</postCode>
									<settlement>San Francisco</settlement>
									<region>CA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff225">
								<orgName type="institution">National Institute of Oncology</orgName>
								<address>
									<settlement>Budapest</settlement>
									<country key="HU">Hungary</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff226">
								<orgName type="department">Center for Clinical Cancer Genetics and Global Health</orgName>
								<orgName type="institution">University of Chicago Medical Center</orgName>
								<address>
									<addrLine>5841 South Maryland Avenue</addrLine>
									<postCode>2115</postCode>
									<settlement>Chicago</settlement>
									<region>MC, IL</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff227">
								<orgName type="department">Department of Oncology</orgName>
								<orgName type="institution">Lund University Hospital</orgName>
								<address>
									<settlement>Lund</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff228">
								<orgName type="department">207 West Midlands Regional Genetics Service</orgName>
								<orgName type="institution">The Ohio State University and the James Cancer Center</orgName>
								<address>
									<settlement>Columbus</settlement>
									<region>Ohio</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff229">
								<orgName type="institution">Birmingham Women&apos;s Hospital Healthcare NHS Trust</orgName>
								<address>
									<addrLine>Edgbaston</addrLine>
									<settlement>Birmingham</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff230">
								<orgName type="department">Julius Center for Health Sciences and Primary Care</orgName>
								<orgName type="institution">UMC Utrecht</orgName>
								<address>
									<settlement>Utrecht</settlement>
									<country key="NL">the Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff231">
								<orgName type="institution" key="instit1">The Breast Cancer Now Toby Robins Research Centre</orgName>
								<orgName type="institution" key="instit2">The Institute of Cancer Research</orgName>
								<address>
									<addrLine>237 Fulham Road</addrLine>
									<postCode>SW3 6JB</postCode>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff232">
								<orgName type="laboratory">Molecular and Nutritional Epidemiology Unit</orgName>
								<orgName type="institution">Cancer Research and Prevention Institute ISPO</orgName>
								<address>
									<settlement>Florence</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff233">
								<orgName type="department">Department of Biomedical, Experimental and Clinical Sciences</orgName>
								<orgName type="institution" key="instit1">Unit of Medical Genetics</orgName>
								<orgName type="institution" key="instit2">University of Florence</orgName>
								<address>
									<settlement>Florence</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff234">
								<orgName type="department">Institute of Cancer Sciences</orgName>
								<orgName type="laboratory">Cancer Research UK Clinical Trials Unit</orgName>
								<orgName type="institution">University of Glasgow</orgName>
								<address>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff235">
								<orgName type="department" key="dep1">Department of Epidemiology</orgName>
								<orgName type="department" key="dep2">School of Public Health</orgName>
								<orgName type="institution">University of Michigan</orgName>
								<address>
									<settlement>Ann Arbor</settlement>
									<region>Michigan</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff236">
								<orgName type="department" key="dep1">Section of Molecular Diagnostics</orgName>
								<orgName type="department" key="dep2">Clinical Biochemistry</orgName>
								<orgName type="institution">Aalborg University Hospital</orgName>
								<address>
									<settlement>Aalborg</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff237">
								<orgName type="department">Department of Genetics</orgName>
								<orgName type="institution">Portuguese Oncology Institute</orgName>
								<address>
									<addrLine>Rua Dr. AntÃ³nio Bernardino de Almeida</addrLine>
									<postCode>4200-072, 216 IFOM</postCode>
									<settlement>Porto</settlement>
									<country key="PT">Portugal</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff238">
								<orgName type="institution">The FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff239">
								<orgName type="institution">IFOM-IEO campus</orgName>
								<address>
									<addrLine>via Adamello 16</addrLine>
									<postCode>20139</postCode>
									<settlement>Milan</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff240">
								<orgName type="department">Dept of Phelan et al</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff241">
								<orgName type="department">OB/GYN</orgName>
								<orgName type="institution">Medical University of Vienna and Comprehensive Cancer Center</orgName>
								<address>
									<addrLine>Waehringer Guertel 18-20</addrLine>
									<postCode>A 1090</postCode>
									<settlement>Vienna, Vienna</settlement>
									<country>Austria, Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff242">
								<orgName type="department" key="dep1">Division of Cancer Medicine</orgName>
								<orgName type="department" key="dep2">219 NRG Oncology, Statistics and Data Management Center</orgName>
								<orgName type="department" key="dep3">Roswell Park Cancer Institute</orgName>
								<address>
									<addrLine>Peter MacCallum Cancer Centre, Locked Bag 1, A&apos;Beckett St, Elm St &amp; Carlton St</addrLine>
									<postCode>8006, 14263</postCode>
									<settlement>East Melbourne, Buffalo</settlement>
									<region>Victoria, NY</region>
									<country>Australia, USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff243">
								<orgName type="department">Department of Epidemiology and Biostatistics</orgName>
								<orgName type="institution">Memorial Sloan Kettering Cancer Center</orgName>
								<address>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff244">
								<orgName type="department" key="dep1">Channing Division of Network Medicine</orgName>
								<orgName type="department" key="dep2">Brigham and Women&apos;s Hospital</orgName>
								<orgName type="institution">Harvard Medical School</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff245">
								<orgName type="institution" key="instit1">South East of Scotland Regional Genetics Service</orgName>
								<orgName type="institution" key="instit2">Western General Hospital</orgName>
								<address>
									<settlement>Edinburgh</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff246">
								<orgName type="laboratory">Service de GÃ©nÃ©tique Clinique Chromosomique et MolÃ©culaire</orgName>
								<address>
									<addrLine>Centre Hospitalier Universitaire de St Etienne</addrLine>
									<postCode>224</postCode>
									<settlement>St Etienne</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff247">
								<orgName type="laboratory">Translational Research Laboratory</orgName>
								<orgName type="institution" key="instit1">IDIBELL (Bellvitge Biomedical Research Institute)</orgName>
								<orgName type="institution" key="instit2">Catalan Institute of Oncology</orgName>
								<address>
									<addrLine>225 UnitÃ© d&apos;OncogÃ©nÃ©tique</addrLine>
									<settlement>Barcelona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff248">
								<orgName type="institution">CHU Arnaud de Villeneuve</orgName>
								<address>
									<settlement>Montpellier</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff249">
								<orgName type="department" key="dep1">Department of Preventive and Predictive Medicine</orgName>
								<orgName type="department" key="dep2">Department of Clinical Genetics</orgName>
								<orgName type="laboratory">Unit of Molecular Bases of Genetic Risk and Genetic Testing</orgName>
								<orgName type="institution">Fondazione IRCCS Istituto Nazionale Tumori (INT)</orgName>
								<address>
									<postCode>227</postCode>
									<settlement>Milan</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff250">
								<orgName type="institution">Karolinska University Hospital</orgName>
								<address>
									<postCode>228</postCode>
									<settlement>Stockholm</settlement>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff251">
								<orgName type="department" key="dep1">Department of Community Medicine and Epidemiology</orgName>
								<orgName type="department" key="dep2">Carmel Medical Center and B. Rappaport Faculty of Medicine</orgName>
								<orgName type="department" key="dep3">Brigham and Women&apos;s Hospital</orgName>
								<orgName type="institution">Clalit National Israeli Cancer Control Center</orgName>
								<address>
									<postCode>229</postCode>
									<settlement>Haifa</settlement>
									<country key="IL">Israel</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff252">
								<orgName type="institution">Dana-Farber Cancer Institute</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff253">
								<orgName type="department" key="dep1">Clinical Genetics Service</orgName>
								<orgName type="department" key="dep2">Department of Medicine</orgName>
								<orgName type="institution">Memorial Sloan Kettering Cancer Center</orgName>
								<address>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff254">
								<orgName type="department">Division of Gynecologic Oncology</orgName>
								<orgName type="institution" key="instit1">NorthShore University HealthSystem</orgName>
								<orgName type="institution" key="instit2">University of Chicago</orgName>
								<address>
									<settlement>Evanston</settlement>
									<region>IL</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff255">
								<orgName type="department" key="dep1">Hereditary Endocrine Cancer group</orgName>
								<orgName type="department" key="dep2">Spanish National Cancer Research Center (CNIO)</orgName>
								<orgName type="institution">Biomedical Network on Rare Diseases (CIBERER)</orgName>
								<address>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff256">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution">Netherlands Cancer Institute</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff257">
								<orgName type="department" key="dep1">Program in Epidemiology</orgName>
								<orgName type="department" key="dep2">Division of Public Health Sciences</orgName>
								<orgName type="department" key="dep3">235 Epidemiology Branch</orgName>
								<orgName type="department" key="dep4">Division of Intramural Research</orgName>
								<orgName type="institution">Fred Hutchinson Cancer Research Center</orgName>
								<address>
									<settlement>Seattle</settlement>
									<region>WA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff258">
								<orgName type="institution" key="instit1">National Institute of Environmental Health Sciences</orgName>
								<orgName type="institution" key="instit2">NIH</orgName>
								<address>
									<addrLine>Research Triangle Park</addrLine>
									<region>NC</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff259">
								<orgName type="department" key="dep1">Division of Human Genetics</orgName>
								<orgName type="department" key="dep2">Department of Internal Medicine</orgName>
								<orgName type="department" key="dep3">The Comprehensive Cancer Center</orgName>
								<orgName type="institution" key="instit1">Clinical Cancer Genetics Program</orgName>
								<orgName type="institution" key="instit2">The Ohio State University</orgName>
								<address>
									<settlement>Columbus</settlement>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff260">
								<orgName type="institution" key="instit1">UniversitÃ© Paris-Saclay</orgName>
								<orgName type="institution" key="instit2">UniversitÃ© Paris-Sud</orgName>
								<orgName type="institution" key="instit3">UVSQ</orgName>
								<orgName type="institution" key="instit4">CESP</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff261">
								<orgName type="institution">INSERM</orgName>
								<address>
									<addrLine>238 Gustave Roussy</addrLine>
									<postCode>F-94805</postCode>
									<settlement>Villejuif, Villejuif</settlement>
									<country>France, France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff262">
								<orgName type="institution">Human Genetics Foundation (HuGeF)</orgName>
								<address>
									<settlement>Torino</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff263">
								<orgName type="institution">Cancer Council Victoria and University of Melbourne</orgName>
								<address>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff264">
								<orgName type="department" key="dep1">Department of Hematology and Oncology</orgName>
								<orgName type="department" key="dep2">Medical Center</orgName>
								<orgName type="institution">University of Kansas</orgName>
								<address>
									<settlement>Kansas City</settlement>
									<region>KS</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff265">
								<orgName type="department">Department of Gynaecological Oncology</orgName>
								<orgName type="institution">Glasgow Royal Infirmary</orgName>
								<address>
									<settlement>Glasgow</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff266">
								<orgName type="laboratory">North East Thames Regional Genetics Service</orgName>
								<orgName type="institution">Great Ormond Street Hospital for Children NHS Trust</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff267">
								<orgName type="department" key="dep1">DÃ©partement Oncologie GÃ©nÃ©tique</orgName>
								<orgName type="department" key="dep2">PrÃ©vention et DÃ©pistage</orgName>
								<orgName type="institution" key="instit1">INSERM CIC-P9502</orgName>
								<orgName type="institution" key="instit2">Institut Paoli-Calmettes/UniversitÃ© d&apos;Aix-Marseille II</orgName>
								<address>
									<settlement>Marseille</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff268">
								<orgName type="department">Department of Pathology</orgName>
								<orgName type="laboratory">Genetic Epidemiology Laboratory</orgName>
								<orgName type="institution">University of Melbourne</orgName>
								<address>
									<settlement>Parkville</settlement>
									<region>VIC</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff269">
								<orgName type="department">Institute of Human Genetics</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff270">
								<orgName type="department">Hannover Medical School</orgName>
								<address>
									<settlement>Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff271">
								<orgName type="department">Department of Cancer Prevention Phelan et al</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff272">
								<orgName type="department" key="dep1">Roswell Park Cancer Institute</orgName>
								<orgName type="department" key="dep2">248 Epidemiology Center</orgName>
								<orgName type="department" key="dep3">College of Medicine</orgName>
								<orgName type="institution">University of South Florida</orgName>
								<address>
									<settlement>Buffalo, Tampa</settlement>
									<region>NY, Florida</region>
									<country>USA, USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff273">
								<orgName type="department" key="dep1">Institute of Human Genetics</orgName>
								<orgName type="department" key="dep2">Department of Human Genetics</orgName>
								<orgName type="institution">University Hospital Heidelberg</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff274">
								<orgName type="department">Division of Breast Cancer Research</orgName>
								<orgName type="institution">The Institute of Cancer Research</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff275">
								<orgName type="institution">National Human Genome Research Institute</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff276">
								<orgName type="institution">National Institutes of Health</orgName>
								<address>
									<settlement>Bethesda</settlement>
									<region>MD</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff277">
								<orgName type="department" key="dep1">Department of Genetics</orgName>
								<orgName type="department" key="dep2">Biomedical Sciences Institute (ICBAS)</orgName>
								<orgName type="institution">Portuguese Oncology Institute</orgName>
								<address>
									<addrLine>Rua Dr. AntÃ³nio Bernardino de Almeida</addrLine>
									<postCode>4200-072</postCode>
									<settlement>Porto</settlement>
									<country key="PT">Portugal</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff278">
								<orgName type="institution">University of Porto</orgName>
								<address>
									<settlement>Porto</settlement>
									<country key="PT">Portugal</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff279">
								<orgName type="laboratory">Cancer Research Initiatives Foundation</orgName>
								<orgName type="institution">Sime Darby Medical Centre</orgName>
								<address>
									<addrLine>Subang Jaya</addrLine>
									<country key="MY">Malaysia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff280">
								<orgName type="department">Faculty of Medicine</orgName>
								<orgName type="institution" key="instit1">254 University Malaya Cancer Research Institute</orgName>
								<orgName type="institution" key="instit2">University Malaya Medical Centre</orgName>
								<address>
									<addrLine>University Malaya</addrLine>
									<settlement>Kuala Lumpur</settlement>
									<country key="MY">Malaysia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff281">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution">Harvard T. Chan School of Public Health</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff282">
								<orgName type="department">Cedars-Sinai Medical Center</orgName>
								<orgName type="institution" key="instit1">Cancer Prevention and Control</orgName>
								<orgName type="institution" key="instit2">Samuel Oschin Comprehensive Cancer Institute</orgName>
								<address>
									<settlement>Los Angeles</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff283">
								<orgName type="institution" key="instit1">Magee-Womens Hospital of UPMC</orgName>
								<orgName type="institution" key="instit2">University of Pittsburgh School of Medicine</orgName>
								<address>
									<settlement>Pittsburgh</settlement>
									<region>PA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff284">
								<orgName type="department">Latvian Biomedical Research and Study Centre</orgName>
								<address>
									<addrLine>Ratsupites str 1</addrLine>
									<settlement>Riga</settlement>
									<country key="LV">Latvia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff285">
								<orgName type="department">Department of Medical Genetics</orgName>
								<orgName type="laboratory">Ovarian Cancer Research (OVCARE) Program -Cheryl Brown Ovarian Cancer Outcomes Unit (CBOCOU)</orgName>
								<orgName type="institution">BC Cancer Agency</orgName>
								<address>
									<postBox>Box 134</postBox>
									<postCode>260</postCode>
									<settlement>Vancouver, Level</settlement>
									<region>British Columbia CANADA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff286">
								<orgName type="department">Addenbrooke&apos;s Treatment Centre</orgName>
								<orgName type="institution">Addenbrooke&apos;s Hosptital</orgName>
								<address>
									<addrLine>Hills Road</addrLine>
									<postCode>CB2 0QQ</postCode>
									<settlement>Cambridge</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff287">
								<orgName type="department">Departments of Internal Medicine and Molecular Virology, Immunology and Medical Genetics</orgName>
								<orgName type="laboratory">Divison of Human Cancer Genetics</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff288">
								<orgName type="department">Comprehensive Cancer Center</orgName>
								<orgName type="institution">The Ohio State University</orgName>
								<address>
									<settlement>Columbus</settlement>
									<region>OH</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff289">
								<orgName type="department" key="dep1">Cancer Epidemiology Unit</orgName>
								<orgName type="department" key="dep2">Department of Population Health</orgName>
								<orgName type="institution">University of Oxford</orgName>
								<address>
									<settlement>Nuffield, Oxford</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff290">
								<orgName type="department" key="dep1">264 WHO Collaborating Center for Nutrition and Health</orgName>
								<orgName type="department" key="dep2">Unit of Nutritional Epidemiology and Nutrition in Public Health</orgName>
								<orgName type="department" key="dep3">Dept. of Hygiene, Epidemiology and Medical Statistics</orgName>
								<orgName type="institution">Hellenic Health Foundation</orgName>
								<address>
									<settlement>Athens</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff291">
								<orgName type="institution">University of Athens Medical School</orgName>
								<address>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff292">
								<orgName type="department">Department of Medical Oncology</orgName>
								<orgName type="institution">Beth Israel Deaconess Medical Center</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff293">
								<orgName type="department" key="dep1">Division of Gynecologic Oncology</orgName>
								<orgName type="department" key="dep2">Department of Obstetrics and Gynaecology</orgName>
								<orgName type="institution">Radboud University Medical Centre</orgName>
								<address>
									<settlement>Nijmegen</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff294">
								<orgName type="department">Department of Genetics</orgName>
								<orgName type="institution" key="instit1">University Medical Center</orgName>
								<orgName type="institution" key="instit2">Groningen University</orgName>
								<address>
									<settlement>Groningen</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff295">
								<orgName type="department">Department of Medical Genetics</orgName>
								<orgName type="institution">University Medical Center Utrecht</orgName>
								<address>
									<settlement>Utrecht</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff296">
								<orgName type="department" key="dep1">Division of Gynecologic Oncology</orgName>
								<orgName type="department" key="dep2">Department of Obstetrics and Gynaecology and Leuven Cancer Institute</orgName>
								<orgName type="institution">University Hospitals Leuven</orgName>
								<address>
									<settlement>Leuven</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff297">
								<orgName type="department" key="dep1">Institute of Human Genetics</orgName>
								<orgName type="department" key="dep2">FundaciÃ³n PÃºblica Galega de Medicina XenÃ³mica</orgName>
								<orgName type="institution">Servizo Galego de SaÃºde (SERGAS)</orgName>
								<address>
									<addrLine>Campus Virchov Klinikum</addrLine>
									<postCode>271</postCode>
									<settlement>Charite Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff298">
								<orgName type="department" key="dep1">Grupo de Medicina XenÃ³mica</orgName>
								<orgName type="department" key="dep2">Centro de InvestigaciÃ³n BiomÃ©dica en Red de Enfermedades Raras (CIBERER)</orgName>
								<orgName type="institution">Instituto de Investigaciones Sanitarias (IDIS)</orgName>
								<address>
									<addrLine>Santiago de Compostela</addrLine>
									<postCode>272</postCode>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff299">
								<orgName type="department">273 Vanderbilt Epidemiology Center</orgName>
								<orgName type="institution">Universidade de Santiago de Compostela (USC)</orgName>
								<address>
									<addrLine>Santiago de Compostela</addrLine>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff300">
								<orgName type="department">Department of Obstetrics and Gynecology</orgName>
								<orgName type="institution" key="instit1">Vanderbilt Genetics Institute</orgName>
								<orgName type="institution" key="instit2">Vanderbilt University Medical Center</orgName>
								<address>
									<settlement>Nashville</settlement>
									<region>TN</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff301">
								<orgName type="department">Oxford Regional Genetics Service</orgName>
								<orgName type="institution">Churchill Hospital</orgName>
								<address>
									<settlement>Oxford</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff302">
								<orgName type="department">Institute of Human Genetics</orgName>
								<orgName type="institution">University Hospital</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff303">
								<orgName type="department">Phelan et al</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff304">
								<address>
									<settlement>Leipzig</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff305">
								<orgName type="department">Department of Obstetrics and Gynecology</orgName>
								<orgName type="institution">University of Ulm</orgName>
								<address>
									<settlement>Ulm</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff306">
								<orgName type="department">Population Health Department</orgName>
								<orgName type="institution">QIMR Berghofer Medical Research Institute</orgName>
								<address>
									<addrLine>300 Herston Road</addrLine>
									<postCode>4006</postCode>
									<settlement>Herston</settlement>
									<region>QLD</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff307">
								<orgName type="department" key="dep1">Biostatistics and Computational Biology Branch</orgName>
								<orgName type="department" key="dep2">Division of Intramural Research</orgName>
								<orgName type="institution" key="instit1">National Institute of Environmental Health Sciences</orgName>
								<orgName type="institution" key="instit2">NIH</orgName>
								<address>
									<addrLine>Research Triangle Park</addrLine>
									<region>NC</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff308">
								<orgName type="department">Clinical Cancer Genetics</orgName>
								<orgName type="institution">City of Hope</orgName>
								<address>
									<settlement>Duarte</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff309">
								<orgName type="department">Department of Data Management Science</orgName>
								<orgName type="institution">Stanford University School of Medicine</orgName>
								<address>
									<settlement>Stanford</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff310">
								<orgName type="department">Department of Human Genetics and Department of Clinical Genetics</orgName>
								<orgName type="institution">Leiden University Medical Center</orgName>
								<address>
									<settlement>Leiden</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff311">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution">University of California Irvine</orgName>
								<address>
									<settlement>Irvine</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff312">
								<orgName type="institution" key="instit1">Women&apos;s College Research Institute</orgName>
								<orgName type="institution" key="instit2">University of Toronto</orgName>
								<address>
									<settlement>Toronto</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff313">
								<orgName type="department" key="dep1">Center for Genomic Medicine</orgName>
								<orgName type="department" key="dep2">Department of Biomedical Data Science</orgName>
								<orgName type="department" key="dep3">Geisel School of Medicine at Dartmouth</orgName>
								<orgName type="institution">Williamson Translational Research Building</orgName>
								<address>
									<postCode>7261, 03756</postCode>
									<settlement>Room</settlement>
									<region>HB, NH</region>
									<country>Lebanon, USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff314">
								<orgName type="department">Department of Public Health Sciences</orgName>
								<orgName type="institution">The University of Virginia</orgName>
								<address>
									<settlement>Charlottesville</settlement>
									<region>VA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff315">
								<orgName type="department">School of Women&apos;s and Children&apos;s Health</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff316">
								<orgName type="department">Lowy Cancer Research Centre</orgName>
								<orgName type="institution">The University of New South Wales UNSW Sydney NSW</orgName>
								<address>
									<postCode>2052</postCode>
									<country key="AU">AUSTRALIA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff317">
								<orgName type="department">The Kinghorn Cancer Centre</orgName>
								<orgName type="institution">Garvan Institute of Medical Research</orgName>
								<address>
									<addrLine>384 Victoria Street</addrLine>
									<postCode>2010</postCode>
									<settlement>Darlinghurst</settlement>
									<region>NSW</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff318">
								<orgName type="department">Department of Molecular Medicine</orgName>
								<orgName type="institution">University La Sapienza, c/oPoliclinico Umberto I</orgName>
								<address>
									<addrLine>viale Regina Elena 324</addrLine>
									<postCode>00161</postCode>
									<settlement>Rome</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff319">
								<orgName type="department" key="dep1">Department of Biomedical Sciences</orgName>
								<orgName type="department" key="dep2">Cedars-Sinai Medical Center</orgName>
								<orgName type="institution">289 Community and Population Health Research Institute</orgName>
								<address>
									<settlement>Los Angeles</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff320">
								<orgName type="department" key="dep1">Department of Preventive Medicine</orgName>
								<orgName type="department" key="dep2">College of Medicine</orgName>
								<orgName type="institution">Seoul National University</orgName>
								<address>
									<addrLine>103 Daehak-ro, Jongno-gu</addrLine>
									<postCode>110-799</postCode>
									<settlement>Seoul</settlement>
									<country key="KR">Korea</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff321">
								<orgName type="institution">Seoul National University Cancer Research Institute</orgName>
								<address>
									<addrLine>103 Daehak-ro, Jongno-gu</addrLine>
									<postCode>110-799</postCode>
									<settlement>Seoul</settlement>
									<country key="KR">Korea</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff322">
								<orgName type="department" key="dep1">Department of Biomedical Science</orgName>
								<orgName type="department" key="dep2">Graduate School</orgName>
								<orgName type="institution">Seoul National University</orgName>
								<address>
									<addrLine>103 Daehak-ro, Jongno-gu</addrLine>
									<postCode>110-799</postCode>
									<settlement>Seoul</settlement>
									<country key="KR">Korea</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff323">
								<orgName type="department" key="dep1">Department of Public Health Sciences</orgName>
								<orgName type="department" key="dep2">College of Medicine</orgName>
								<orgName type="department" key="dep3">Department of Chronic Disease Epidemiology</orgName>
								<orgName type="institution">Medical University of South Carolina</orgName>
								<address>
									<postCode>29425 294</postCode>
									<settlement>Charleston</settlement>
									<region>SC</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff324">
								<orgName type="institution">Yale School of Public Health</orgName>
								<address>
									<settlement>New Haven</settlement>
									<region>CT</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff325">
								<orgName type="department" key="dep1">Department of Biomedical Sciences</orgName>
								<orgName type="department" key="dep2">Cedars-Sinai Medical Center</orgName>
								<address>
									<settlement>Los Angeles</settlement>
									<region>California</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Identification of twelve new susceptibility loci for different histotypes of epithelial ovarian cancer</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2017-11-01">2017 November 01.</date>
						</imprint>
					</monogr>
					<idno type="MD5">2DA3DE165BD9063F6CAF5408DBC71D7C</idno>
					<idno type="DOI">10.1038/ng.3826</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:38+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>.</term>
					<term>J.M.</term>
					<term>S.A.N.</term>
					<term>K.L.N.</term>
					<term>L. N.</term>
					<term>R.B.N.</term>
					<term>S.L.N.</term>
					<term>H.N.</term>
					<term>D.N.</term>
					<term>R.L.N.</term>
					<term>K.Odunsi</term>
					<term>K.Offit</term>
					<term>E.O.</term>
					<term>O.I.O.</term>
					<term>H.O.</term>
					<term>C.O.</term>
					<term>D.M.O&apos;M.</term>
					<term>K-R.O.</term>
					<term>N.C.O.-M.</term>
					<term>N.O.</term>
					<term>S.O.</term>
					<term>A.O.</term>
					<term>L.O.</term>
					<term>D.P.</term>
					<term>L.Papi</term>
					<term>S.K.P.</term>
					<term>T-W.P.-S.</term>
					<term>J.P.</term>
					<term>C.L.P.</term>
					<term>I.S.P.</term>
					<term>P.H.M.P.</term>
					<term>B.Peissel</term>
					<term>A.Peixoto</term>
					<term>T.Pejovic</term>
					<term>L.M.P.</term>
					<term>J.B.P.</term>
					<term>P.Peterlongo</term>
					<term>L.P.</term>
					<term>G.P.</term>
					<term>P.D.P.P.</term>
					<term>C.M.P.</term>
					<term>K.-A.P.</term>
					<term>M.P.</term>
					<term>M.C.P.</term>
					<term>A.M.P.</term>
					<term>S.R.P.</term>
					<term>T.Pocza</term>
					<term>E.M.P.</term>
					<term>B.Poppe</term>
					<term>M.E.P.</term>
					<term>F.P.</term>
					<term>D.P.</term>
					<term>M.A.P.</term>
					<term>L.Szafron</term>
					<term>Y.Y.T.</term>
					<term>J.A.T.</term>
					<term>M.-K.T.</term>
					<term>M.R.T.</term>
					<term>S.-H.T.</term>
					<term>K.L.T.</term>
					<term>M.Thomassen</term>
					<term>P.J.T.</term>
					<term>L.C.V.T.</term>
					<term>D.L.T.</term>
					<term>L.T.</term>
					<term>A.V.T.</term>
					<term>M.Tischkowitz</term>
					<term>S.T.</term>
					<term>A.E.T.</term>
					<term>A.Tone</term>
					<term>B.T.</term>
					<term>R.T.</term>
					<term>A. Trichopoulou</term>
					<term>N.T.</term>
					<term>S.S.T.</term>
					<term>A.M.V.A.</term>
					<term>D.V.D.B.</term>
					<term>A.H.V.D.H.</term>
					<term>R.B.V.D.L.</term>
					<term>M.V.H.</term>
					<term>E.V.N.</term>
					<term>E.J.V.R.</term>
					<term>A.Vanderstichele</term>
					<term>R.V.-M.</term>
					<term>A.Vega</term>
					<term>D.V.E.</term>
					<term>I.V.</term>
					<term>J.V.</term>
					<term>R.A.V.</term>
					<term>A.Vratimos</term>
					<term>L.W.</term>
					<term>C.W.</term>
					<term>D.W.</term>
					<term>S.W.-G.</term>
					<term>B.W.</term>
					<term>P.M.W.</term>
					<term>C.R.W.</term>
					<term>J.N.W.</term>
					<term>N.W.</term>
					<term>A.S.W.</term>
					<term>J.T.W.</term>
					<term>L.R.W.</term>
					<term>A.W.</term>
					<term>M.W.</term>
					<term>A.H.W.</term>
					<term>X.W.</term>
					<term>H.Y.</term>
					<term>D.Y.</term>
					<term>A.Z.</term>
					<term>K.K.Z</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>To identify common alleles associated with different histotypes of epithelial ovarian cancer (EOC), we pooled data from multiple genome-wide genotyping projects totaling 25,509 EOC cases and 40,941 controls.</s><s>We identified nine new susceptibility loci for different EOC histotypes: six for serous EOC histotypes (3q28, 4q32.3,</s><s>8q21.11,</s><s>10q24.33,</s><s>18q11.2 and 22q12.1),</s><s>two for mucinous EOC (3q22.3,</s><s>9q31.1) and one for endometrioid EOC (5q12.3).</s><s>We then meta-analysed the results for high-grade serous ovarian cancer with the results from analysis of 31,448 BRCA1 and BRCA2 mutation carriers, including 3,887 mutation carriers with EOC.</s><s>This identified an additional three loci at 2q13, 8q24.1 and 12q24.31.</s><s>Integrated analyses of genes and regulatory biofeatures at each locus predicted candidate susceptibility genes, including OBFC1, a novel susceptibility gene for low grade/borderline serous EOC.</s></p><p><s>Epithelial ovarian cancer (EOC) is a heterogeneous disease commonly classified into five major histotypes of invasive disease 1 -(high grade serous (HGSOC), low grade serous (LGSOC), mucinous (MOC), endometrioid (ENOC) and clear cell carcinoma (CCOC))and two histotypes of borderline disease -serous and mucinous.</s><s>The histotypes have differences in lifestyle and genetic risk factors, precursor lesions, patterns of spread, molecular events during oncogenesis, response to chemotherapy, and prognosis.</s><s>HGSOC are thought to be derived from fallopian tube secretory epithelial cells through foci of endosalpingiosis existing as inclusion cysts lined with tubal epithelium at the ovarian and peritoneal surface 2 .</s><s>In contrast, CCOC, ENOC, and sero-endometrioid carcinomas appear to develop from endometriosis <ref type="bibr" target="#b5">3,</ref><ref type="bibr" target="#b6">4</ref> .</s><s>MOC resembles adenocarcinoma of the gastric pylorus, intestine, or endocervix and the majority of these tumors show gastrointestinal differentiation 5 .</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Approximately 20% of the familial component of EOC risk is attributable to high-tointermediate risk genes <ref type="bibr" target="#b8">6</ref> .</s><s>An unknown fraction is due to more common, lower risk genetic variation <ref type="bibr">7</ref> .</s><s>In European populations, genome-wide association studies (GWAS) have identified 23 EOC susceptibility alleles including 18 common variants associated with all histologies and/or serous EOC <ref type="bibr">[8]</ref><ref type="bibr" target="#b11">[9]</ref><ref type="bibr">[10]</ref><ref type="bibr" target="#b13">[11]</ref><ref type="bibr" target="#b14">[12]</ref><ref type="bibr">[13]</ref><ref type="bibr">[14]</ref><ref type="bibr">[15]</ref> , one with borderline serous tumors <ref type="bibr">13</ref> , three with MOC <ref type="bibr">16</ref> and one with CCOC <ref type="bibr" target="#b14">12</ref> .</s><s>The majority of these loci also showed associations (p&lt;0.05) with EOC risk for BRCA1 or BRCA2 mutation carriers <ref type="bibr">15</ref> .</s><s>Five additional loci associated with EOC and breast and/or prostate cancer have been identified <ref type="bibr">17</ref> ; three of these were associated with susceptibility to EOC, breast and prostate cancers, and two were associated only with breast and EOC risk.</s><s>However, the common genetic variants explain only 3.9% of the inherited component of EOC risk <ref type="bibr">15</ref> and additional susceptibility loci are likely to exist, particularly for the less common, non-serous histotypes.</s></p><p><s>We designed a custom Illumina array named the 'OncoArray', in order to identify new cancer susceptibility loci <ref type="bibr" target="#b20">18</ref> .</s><s>The OncoArray includes ~533,000 variants (of which 260,660 formed a GWAS backbone) and has been used to genotype over 500,000 samples, including EOC case-control studies of the Ovarian Cancer Association Consortium (OCAC) and BRCA1 and BRCA2 mutation carriers of the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).</s><s>These data were combined with genotype data from the Collaborative Oncological Gene-environment Study (COGS) project <ref type="bibr">14,</ref><ref type="bibr">19</ref> and three EOC GWAS <ref type="bibr">8,</ref><ref type="bibr" target="#b11">9</ref> .</s><s>We present the results of these association analyses together with functional annotation of the new genome-wide significant EOC susceptibility loci.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Association analyses</head><p><s>Genetic association analyses were performed using genotype data from 25,509 populationbased EOC cases and 40,941 controls from OCAC and meta-analysis of these data with 19,036 BRCA1 and 12,412 BRCA2 mutation carriers from CIMBA, of whom 2,933 and 954, respectively, were affected with EOC.</s><s>The numbers of participants by study for OCAC and CIMBA are shown in Supplementary table 1 and Supplementary table 2, respectively.</s></p><p><s>We used data from the 1000 Genomes Project <ref type="bibr">20</ref> reference panel to impute genotypes for 11,403,952 common variants (MAF&gt;1%) and evaluated the associations of these SNPs with EOC risk.</s><s>In OCAC alone, nine histotypes were investigated (all invasive, serous invasive, HGSOC, LGSOC, serous borderline, LGSOC and serous borderline combined, ENOC, CCOC and MOC).</s><s>Association analyses revealed six novel loci associated with serous EOC histotypes at genome-wide significance (p&lt;5Ã10 <ref type="bibr">-8</ref> ): rs9870207 at 3q28, rs13113999 at 4q32.3, rs150293538 at 8q21.11, rs7902587 at 10q24.33, rs8098244 at 18q11.2 and rs6005807 at 22q12.1.</s><s>Five of these loci were associated with borderline serous EOC (3q28, 4q32.3,</s><s>8q21.11,</s><s>10q24.33 and 18q11.2) and four with LGSOC tumors (3q28, 8q21.11,</s><s>10q24.33 and 18q11.2) (Table <ref type="table" target="#tab_0">1</ref>).</s><s>We also identified two loci associated with MOC (rs112071820 at 3q22.3 and rs320203 at 9q31.1) and one locus associated with ENOC (rs555025179 at 5q12.3).</s><s>The meta-analysis of OCAC and CIMBA revealed three additional serous EOC loci (rs2165109 at 2q13; rs9886651 at 8q24.21; rs7953249 at 12q24.31).</s><s>The 8q24.21 SNP rs9886651 is close to two SNPs previously associated with serous EOC <ref type="bibr" target="#b11">9</ref> (and Gjyshi A, Mendoza-Fandino G, Tyrer J, Woods NT, Lawrenson K et al., personal  communication).</s><s>Multi-variable analysis of OCAC data showed that this is a third independent-associated variant in this region (unadjusted OR = 1.07,</s><s>OR adjusted for rs1400482 and rs13255292 =1.07).</s><s>Variant rs6005807 at 22q12.1 was previously reported to be associated with serous EOC at sub-genome-wide significance <ref type="bibr">21</ref> .</s></p><p><s>The association of the top SNP in each region with the nine EOC histotypes studied with EOC risk in BRCA1 and BRCA2 carriers is shown in Figure <ref type="figure" target="#fig_0">1</ref>.</s><s>Four SNPs, rs8098244 (18q11.2),</s><s>rs2165109 (2q13), rs9886651 (8q24.21),</s><s>rs7953249 (12q24.31)</s><s>showed associations with EOC risk for BRCA1 mutation carriers and one SNP, rs9886651 (8q24.21)</s><s>showed an association with risk for BRCA2 carriers (P&lt;0.05)</s><s>Eighteen of the 23 previously published loci were associated with the same histotype at genome-wide significance (excluding the 5 pleitropic loci published by Kar et al, Supplementary table <ref type="table">3</ref>).</s><s>Of these, 11 showed an association with EOC risk for BRCA1 mutation carriers and eight showed an association with risk for BRCA2 carriers (P&lt;0.05).</s></p><p><s>There was significant heterogeneity of risk between the five main, non-overlapping histotypes (high grade serous, low grade/borderline serous, endometrioid, clear cell and invasive/borderline mucinous) for 28 of the 40 new and previously published loci (Supplementary table <ref type="table">3</ref>).</s></p><p><s>We carried out a competing-risks association analysis in BRCA1 and BRCA2 mutation carriers in order to investigate whether the observed associations with ovarian cancer in mutation carriers are influenced by associations with breast cancer risk.</s><s>For this we used the most significantly associated genotyped SNPs for this <ref type="bibr" target="#b24">22</ref> .</s><s>The EOC HR estimates were consistent with the estimates from the main analysis for all SNPs (results not shown).</s><s>Some evidence suggested that rs7953249 at 12q24.31 was associated with reduced breast cancer risk in BRCA1 mutation carriers (HR=0.95,</s><s>95%CI 0.91-0.99,</s><s>p=0.034) and that SNP rs2165109 at 2q13 was associated with increased breast cancer risk in BRCA2 mutation carriers (HR=1.08,</s><s>95%CI 1.01-1.14,</s><s>p=0.02).</s><s>When these associations were analyzed by tumor estrogen-receptor status, the associations for the two SNPs were restricted to ERnegative breast for BRCA1 (p=0.026 for rs7953249) and BRCA2 (p=0.02 for rs2165109) mutation carriers.</s></p><p><s>Association analyses adjusted for the most significant SNP in each region (including 3 independent SNPs at 8q24.21) did not reveal any additional independent association signals in these regions.</s><s>At the 12 new EOC risk regions, 571 SNPs were deemed potentially causal (Supplementary table 4) and carried forward for functional annotation, eQTL and mQTL analyses.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Functional and molecular analyses</head><p><s>Of the 571 candidate causal variants in the 12 novel loci, 562 variants are located in noncoding DNA sequences and may influence the expression of nearby target genes <ref type="bibr" target="#b25">23</ref> .</s><s>We used a variety of in silico approaches to identify putative, tissue-specific, regulatory biofeatures and candidate susceptibility genes associated with risk SNPs at each locus.</s><s>For the few riskassociated, non-synonymous variants in protein coding genes, we also evaluated predicted effects on protein function.</s></p><p><s>Functional annotation of candidate causal alleles-We mapped the set of 562 nonprotein coding candidate causal SNPs at the 12 susceptibility loci to regulatory biofeatures, using a variety of epigenomic marks profiled in normal and cancer tissues relevant to the cellular origins of different ovarian cancer histotypes (Supplementary table <ref type="table">5</ref>).</s><s>The cell types interrogated included: (1) fallopian tube (FT33; FT246) and ovarian surface epithelial cell lines (IOSE4; IOSE11) for serous precursor tissues; (2) serous-related cancer cell lines including HGSOC cell lines (UWB1.289;</s><s>CaOV3) and a LGSOC cell line (OAW42); (3) endometriosis epithelial cells (EEC16), as a likely precursor of ENOC; (4) cell types relevant to MOC, including MOC cell lines (GTFR230; MCAS) and both colonic normal (colon crypt) and cancer tissues (HCT116; HeLa-S3).</s><s>The epigenomic marks annotated were open chromatin, identified using formaldehyde assisted isolation of regulatory element sequencing (FAIRE-seq) and DNase I hypersensitivity sequencing (DNase-seq) and chromatin immunoprecipitation sequencing (ChIP-seq) of histone modifications, specifically histone H3 lysine 27 acetylation (H3K27ac, which denotes active chromatin) and histone H3 lysine 4 monomethylation (H3K4me1, which marks active and poised enhancers).</s><s>SNPs were also intersected with ENCODE transcription factor ChIPseq data.</s><s>All tissue types were evaluated for all risk loci.</s><s>The SNP-biofeature intersections by tissue type are illustrated in Figure <ref type="figure">2</ref> and Supplementary table 6.</s></p><p><s>Nine (1.6%) of the 571 candidate causal SNPs lie in protein coding sequences.</s><s>Five of these are synonymous and four are non-synonymous but predicted to be benign by Polyphen-2 (Supplementary table <ref type="table">6</ref>).</s><s>Four SNPs lie within untranslated regions of protein-coding genes and so could affect mRNA stability: rs1051149 and rs1051150 in the 3' UTR of LAMA3 and rs12327412 in the 5' UTR of TTC39C, all at the 18q11.2</s><s>locus; and rs1018128 in the 3' UTR of GMNC at 3q28.</s><s>The majority of biofeature-SNP intersections (n=166, 29% of all candidate causal SNPs and 97% of candidate causal SNPs overlapping a biofeature) were for SNPs lying within active chromatin, and/or open chromatin.</s><s>Eleven SNPs lie in the promoters of four genes (PVT1, HNF1A, TTC39C and TTC28) (Supplementary Table <ref type="table">6</ref>).</s></p><p><s>At six serous risk loci (4q32.3;</s><s>3q28; 8q21; 18q11; 8q24; 22q12) we observed extensive SNP-biofeature overlaps, particularly in serous-related tissue types.</s><s>In contrast, the two MOC susceptibility loci (3q22.3,</s><s>9q31.1) were biofeature-poor regions and showed little or no SNP-biofeature intersections in any of the tissue types under investigation, including MOC and ENCODE cell lines.</s><s>At the endometrioid EOC risk locus (5q12.3)</s><s>we observed enhancers in endometriosis, ovarian, fallopian and EOC cell types flanking the small number risk associated SNPs (n=8), none of which coincided with regulatory elements.</s></p><p><s>Several studies have shown that common variant susceptibility alleles are significantly enriched for regulatory elements detected in disease-relevant tissue types.</s><s>Therefore we tested for enrichment of SNP-H3K27ac intersections at each locus because H3K27ac was the most comprehensively profiled regulatory feature across different tissue types (Supplementary table <ref type="table">7</ref>).</s><s>At the 12q24.31</s><s> ).</s><s>At 10q24.33 (which is associated with LGSOC and borderline SOC) we identified a significant enrichment of acetylated H3K27 in normal fallopian cells (FT33 P=1.09Ã10 -4 , FT246 P=4.29Ã10 -3 ), HGSOC ovarian cancer cells (UWB1.289</s><s>P=6.23Ã10 -3 ), MOC cells (GTFR230 P=5.16Ã10 -3 ) as well as, somewhat surprisingly, colorectal cancer cells (HCT116 P=2.64Ã10 -4 ) and cervical cancer cells (HeLa-S3 P=9.60Ã10 <ref type="bibr">-12</ref> ).</s><s>This locus contains several clusters of H3K27ac activity and TF binding in ovarian and ENCODE datasets, and these highly active regions showed extensive overlap with candidate causal alleles (Figure <ref type="figure" target="#fig_1">3</ref>).</s></p><p><s>Identifying candidate susceptibility gene targets at risk loci-We used several approaches to identify candidate target genes at the 12 risk loci.</s><s>First, we hypothesized that target genes underlying disease susceptibility are more likely to display prevalent copy number alterations in ovarian tumor tissues.</s><s>Amplifications were the most frequent alteration at 6 of the 12 susceptibility loci (Supplementary figure <ref type="figure" target="#fig_0">1</ref>).</s><s>Contiguous genes were commonly amplified in the same sample indicating segmental amplifications (data not shown).</s><s>HNF1A, ORAI1, CHEK2, XPB1, BUB1, and FOXL2 are found inside the same topologically associating domain (TAD) as candidate causal SNPs and have been previously implicated in ovarian cancer development (Supplementary figure <ref type="figure">2</ref>).</s><s>Notably, HNF1A, ORAI1, and FOXL2 are amplified in &gt;5% of EOC samples.</s><s>No TAD was identified for 8q24.21;</s><s>but MYC and PVT1 appear to be the targets for multiple enhancer elements containing independent EOC risk associations for HGSOC at this locus (Gjyshi et al., personal communication).</s></p><p><s>We also performed expression and methylation quantitative trait locus (eQTL and mQTL) analyses in several data sets comprising methylation/expression profiling and germline genotyping in relevant tumor tissues (see Methods).</s><s>For eQTL analyses, we evaluated associations between the candidate causal SNPs and all genes profiled within 1 Mb of the index risk SNP at each locus, since this window will contain most cis-eQTL associations <ref type="bibr" target="#b25">23</ref> .</s></p><p><s>Results of the eQTL analyses in each data set were adjusted for tumor copy number and methylation status <ref type="bibr" target="#b26">24</ref> and a meta-analysis of the two HGSOC data sets from TCGA and the Mayo Clinic are shown in Supplementary table 8-11.</s><s>The most significant eQTL associations in both HGSOC data sets were identified between the candidate causal risk SNPs at the 10q24.33</s><s>risk locus and OBFC1 expression (TCGA-rs11597399 -P = 3.1 Ã 10 -10 ; Mayo-rs7902587-P = 4.0 Ã 10 -4 ; meta-analysis-rs34379047-P = 2.1 Ã 10 -11 ).</s><s>The risk (T) allele was associated with reduced OBFC1 expression in both data sets (Figure <ref type="figure" target="#fig_1">3d</ref>).</s></p><p><s>We then evaluated all SNPs at this locus (not just the candidate causal SNPs) for eQTL associations; the SNPs with the most significant eQTL associations for OBFC1 were also candidate causal SNPs for the risk association, reinforcing OBFC1 as the target gene.</s><s>No expression associations were identified at P &lt; 10 -4 for the candidate causal risk SNPs at any other locus in the eQTL meta-analysis.</s><s>Thirty-two ENOC samples were used to conduct an eQTL analysis focused on the 5q13.1 ENOC risk locus but this did not reveal any associations at P &lt; 0.05 (Supplementary table <ref type="table" target="#tab_0">10</ref>).</s></p><p><s>Methylation QTL analyses were restricted to the set of 67 CpGs with the most significant association with decreased expression of the 74 genes of interest (within a 1Mb region of the index SNP) in the 12 regions.</s><s>Results are presented for the most significant mQTL associations for each SNP based on the reduced set of CpGs (Supplementary table <ref type="table" target="#tab_0">12</ref>).</s><s>We identified two regions with mQTL associations at P&lt;0.005.</s><s>At 2q13, the risk allele [G] of rs56226558 was associated with reduced methylation of the CpG cg21469370 (p=1.4 Ã 10 -3 ), with methylation being associated with reduced expression of BCL211 (p=1.1Ã10 -</s><s> ) even though cg21469370 lies in the gene body of ACOXL.</s><s>At 3q22.3, the risk allele [C] of rs68088905 was associated with reduced methylation of the CpG cg06726820 in the promoter of RBP1 (mQTL p = 4.9 Ã 10 -3 ).</s><s> ).</s><s>We found no highly significant mQTL associations for genes at any other locus, and the eQTL SNP at 10q24.33 was not association with DNA methylation.</s></p><p><s>SNPs in the 10q24.33</s><s>locus revealed the most significant eQTL with expression of the OBFC1 gene.</s><s>The most significant eQTL SNPs also showed the most epigenetic marks, including rs35007589 (eQTL p-value 2.3Ã10 -11 ), rs35176048 (eQTL p-value 2.6 Ã10 <ref type="bibr">-11</ref> ) and rs34685262 (eQTL p-value 3.8 Ã10 <ref type="bibr">-11</ref> ).</s><s>These SNPs intersect regions of open chromatin, H3K27ac and H3K4me1 signal in normal ovarian and fallopian tube epithelial cells and, for rs35176048 and rs34685262, in HGSOC cell lines.</s><s>These enhancers are not specific to ovarian cell types.</s><s>At this locus, 11 candidate causal SNPs are predicted by motifbreakR <ref type="bibr" target="#b27">25</ref> to alter transcription factor binding sites, of which 8 are predicted to have a strong effect on TF binding (Supplementary table <ref type="table" target="#tab_0">13</ref>).</s><s>Of particular interest, rs2488000 (eQTL p-value = 1.4 Ã 10 -10 ) is predicted in silico to strongly impact the binding of CTCF, a ubiquitously expressed transcriptional regulator that plays a key role in insulator function and chromatin structure (Figure <ref type="figure" target="#fig_1">3c</ref>).</s><s>Furthermore in ENCODE there is evidence from ChIPseq experiments that CTCF does bind at this location in monocytes.</s><s>Other SNPs predicted to have a strong effect on the binding of other cancer-relevant TFs are rs11813268 (ETS1), rs7907606 (FOXP1) and rs2995264 (IRF8) (Supplementary table <ref type="table" target="#tab_0">13</ref>).</s><s>At 8q24.21, the candidate causal variants span a region of ~20kb that includes the promoter and first exon of PVT1, an oncogenic long non-coding RNA (lncRNA) with known roles in breast and ovarian cancer <ref type="bibr" target="#b28">26</ref> .</s><s>The 8q24 region is also a hotspot for association with other cancers 27 with PVT1, CMYC and novel lncRNAs identified as candidate target genes.</s><s>Five SNPs (rs10956390, rs10098831, rs6470578, rs6990534 and rs4410871) coincide with 11 or more biofeatures in normal ovarian and fallopian epithelial cells, and ovarian cancer cells.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>We have identified 12 novel loci associated with different histotypes of EOC at genomewide significance.</s><s>Despite the use of a stringent significance threshold it is possible that some of these represent false positive associations.</s><s>Wakefield has suggested the use of an approximate Bayes factor to calculate the Bayes false discovery probability (BFDP) <ref type="bibr" target="#b30">28</ref> .</s><s>We have estimated the BFDP based on a plausible odds ratio of 1.2 and a prior probability of association of 0.0001.</s><s>The BFDP was less than 10% for 11 of the 12 associations.</s><s>We also calculated the BFDP for the 22 previously reported loci, of which 17 were &lt;1%, 1 was &gt;1% but less than 10% and 4 were greater than 10%.</s><s>We did not calculate the BFDP for the 5 pleiotropic loci reported by Kar et al, 2016 <ref type="bibr">17</ref> .</s><s>These five loci together with the 29 loci with BFDP&lt;10% bring the total number of susceptibility loci for different histotypes of EOC to 34 for women of European ancestry, of which 27 are associated with risk of invasive EOC at P&lt;0.01.</s><s>Assuming a polygenic variance of 1.45 <ref type="bibr" target="#b31">29</ref> the 27 loci account for approximately 6.4% of the polygenic risk in the population.</s><s>Incorporating common EOC susceptibility variants into risk assessment tools will improve risk prediction and may be particularly useful for refining risk estimates in BRCA1 and BRCA2 mutation carriers.</s><s>Some strata in the OCAC analyses pooled data from several studies from the same country.</s><s>This might increase the potential for bias because of population stratification, but we expect any inflation due to population stratification to be effectively removed by adjusting for the principal components.</s><s>In order to evaluate the possible magnitude of such a bias we compared the inflation of the median test statistic for the analysis of the OncoArray data stratified by study with an analysis in which all the cases and controls were combined into a single stratum.</s><s>There was little difference (Î»=1.054</s><s>v Î»=1.078).</s><s>As these inflation factors are not adjusted for sample size, some of the difference is due to the increase in effective sample size of the non-stratified analysis, suggesting that any bias do to pooling data from multiple studies will be minimal.</s></p><p><s>Consistent with previous studies in EOC and other cancer types, the vast majority of the risk-associated variants were located in non-protein coding regions of the genome <ref type="bibr" target="#b32">30</ref> suggesting these variants impact target gene expression by altering the activity of functional element(s) that regulate the expression of one or more susceptibility genes.</s><s>Since noncoding biofeatures, such as enhancers, show a high degree of tissue specificity, we intersected EOC risk SNPs with regions of active chromatin catalogued in cell lines representing the different EOC histotypes (HGSOC, ENOC, LGSOC and MOC) and in EOC precursor cells (OSEC/FTSEC for LGSOC/HGSOC, EEC for ENOC and colonic crypt for MOC).</s><s>Enrichment analyses test for over-representation of cell-type specific biofeatures intersecting risk variants at confirmed risk loci, compared to a lack of enrichment in nondisease associated tissues.</s><s>A major strength of our approach was the ability to interrogate histotype-specific epigenomic profiles and so in addition to identifying the putative functional targets of risk SNPs, these analyses can also indicate whether some cell types are more likely to be relevant to disease pathogenesis compared to other cell types.</s><s>For example we detected a significant enrichment of active chromatin marks coinciding with SNPs in fallopian tube epithelial cells at the 10q24.</s><s>33 LGSOC/borderline serous locus, which could reflect recent pathological evidence that some of these tumors arise in the distal fallopian tube <ref type="bibr" target="#b33">31</ref> , as well as HGSOC <ref type="bibr">2</ref> .</s><s>At the same locus, we also identified an enrichment for biofeatures in a primary MOC cell line, a cancer histotype that is often associated with deregulation of the MAPK pathway; which is also perturbed in LGSOC <ref type="bibr" target="#b34">32</ref> .</s><s>Given the growing evidence that regulatory mechanisms are highly tissue specific, it is perhaps to be expected that we find such enrichments in cell types associated with EOC development.</s><s>However, the lack of enrichment at MOC and ENOC risk loci may indicate that alternative precursor cell types give rise to these histotypes rather than the cell types evaluated in the current study.</s></p><p><s>Expression QTL analysis identified associations between the most statistically significant risk-associated SNPs at 10q24.33 and OBFC1, many of which also coincide with epigenetic biofeatures.</s><s>OBFC1 is a subunit of an alpha accessory factor that stimulates the activity of DNA polymerase-alpha-primase, the enzyme that initiates DNA replication.</s><s>OBFC1 also appears to function in a telomere-associated complex that binds telomeric single-stranded DNA in vitro and localizes at telomeres in vivo <ref type="bibr" target="#b35">33</ref> .</s><s>Four SNPs in this region (rs2487999, rs4387287, rs9420907 and rs9419958) have previously been reported to be associated with telomere length (NHGRI-EBI GWAS catalog <ref type="bibr" target="#b29">27</ref> , Supplementary table <ref type="table" target="#tab_0">14</ref>).</s><s>The r 2 between these and rs7902587 are between 0.52 and 0.93 (1000 Genomes European populations).</s><s>However, the associations of all four with LGSOC and borderline serous EOC are attenuated when adjusted for rs7902587 suggesting a single association peak.</s><s>The alleles associated with a decrease in leukocyte telomere length being associated with an increased risk of LGSOC and borderline serous EOC.</s><s>These findings are consistent with the association between borderline EOC and rs7705526 at 5p15 (adjacent to the telomerase reverse transcriptase gene) <ref type="bibr">13</ref> .</s><s>Furthermore, the histotype specificity is consistent with the suggestion that telomere length differs between the different histotypes of EOC <ref type="bibr" target="#b36">34</ref> .</s></p><p><s>Candidate causal variants at three of the 12 novel loci are associated with multiple traits in the NHGRI-EBI GWAS catalog (P&lt;5Ã10 <ref type="bibr">-8</ref> ).</s><s>These traits converge on pathways involved in inflammation and immunity, including monocyte count, C-reactive protein (CRP) levels, gamma-glutamyl transpeptidase levels, N-glycan levels, allergen sensitization, and multiple sclerosis (Supplementary table 14).</s><s>For example, at the 12q24.31</s><s>HGSOC risk locus, the risk allele of four candidate causal SNPs (rs7979473, rs1183910, rs2393791, rs7310409) have previously been associated with raised CRP levels in blood plasma, a marker of inflammation.</s><s>This is consistent with the established link between chronic inflammation and increased cancer risk.</s><s>In addition SNPs within 500kb of the top SNP at 2q13, 8q24.21,</s><s>10q24.33 and22q12.1 are associated with several different cancers although only one of these is a candidate causal EOC variant (rs2995264 at 10q24.33 associated with cutaneous malignant melanoma).</s></p><p><s>This study demonstrates the strength of large-scale collaborations in identifying common variant risk associations for complex traits such as EOC which is rare, has a high mortality rate, and exhibits heterogeneity by histotype.</s><s>As the largest study to date with over 90,000 EOC cases and controls including an additional ~25,000 previously unstudied participants, we identify several novel risk loci specific to the rarer EOC histotypes: ENOC, MOC,</s></p><p><s>LGSOC and borderline EOC.</s><s>The histotype-specific nature of these associations adds to the somatic, epidemiological and clinical data indicating that EOC histotypes can be thought of as distinct diseases.</s><s>The lack of heterogeneity between studies of varying designs, carried out in different populations, and the high levels of statistical significance, with confirmation of known EOC susceptibility loci, provide evidence that these are robust associations.</s><s>Molecular analyses of genes and the tissue specific regulatory architecture at these loci, which combined publicly available datasets with systematic, large-scale genome wide profiling experiments, point to a small number of non-coding biofeatures and target genes that may play a histotype-specific role in EOC initiation and development.</s><s>Detailed functional studies will be required to define the underlying biology of SNP-regulatory interactions to identify the causal SNP(s) at each locus, and to confirm which candidate susceptibility genes represent the targets of these risk SNPs.</s><s>Evolving technologies, in particular CRISPR-Cas9 genome editing, now enable precision modification of risk SNPs to create isogenic models of different alleles <ref type="bibr" target="#b37">35</ref> , enabling the effects of each allele on disease pathogenesis to be studied, for example at 19p13 36 , 8q24 <ref type="bibr">14</ref> , 17q12 12 and 5p15 <ref type="bibr">13</ref> .</s><s>Finally, given that several previously identified EOC susceptibility alleles are associated with risk of other cancers <ref type="bibr">17</ref> , and that there are similarities in molecular phenotype and/or shared tissue of origin between endometrial cancer, endometriosis and ENOC and CCOC <ref type="bibr" target="#b39">37</ref> as well as basal-like breast cancer <ref type="bibr" target="#b40">38</ref> , we anticipate that the loci reported here may be also associated with risk of other cancer-related traits.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study samples</head><p><s>Genotype data from six OCAC and two CIMBA genotyping projects were used for these analyses (Supplementary table 1).</s><s>All participating studies were approved by the relevant research ethics committee and all participants provided written, informed consent.</s></p><p><s>OCAC-The OCAC OncoArray data comprised 63 genotyping project/case-controls sets (Supplementary table 1).</s><s>Some studies (e.g.</s><s>SEARCH) contributed samples to more than one genotyping project and some case-control sets are a combination of multiple individual studies.</s><s>The following numbers are for the subjects of European ancestry that passed QC.</s><s>The analyses included 66,450 samples from seven genotyping projects: 40,941 controls, 22,406 invasive cases and 3,103 borderline cases.</s><s>The number of cases by histotype were serous borderline (1,954), mucinous borderline (1,149), LGSOC (1,012), HGSOC (13,037), ENOC (2,810), CCOC (1,366) and other EOC (2,764).</s></p><p><s>CIMBA-Eligibility in CIMBA is restricted to females aged 18 years or older with pathogenic variants in BRCA1 or BRCA2.</s><s>The majority of the participants were sampled through cancer genetics clinics, including some related participants.</s><s>Sixty-three studies contributed OncoArray and iCOGS genotype data on 31,448 mutation carriers.</s><s>For the samples genotyped on OncoArray, after quality control (see below), data were available on 15,694 BRCA1 mutation-carriers and 10,988 BRCA2 mutation carriers, of whom 2,372 and 849, respectively, were affected with EOC (Supplementary table <ref type="table">2</ref>).</s><s>We also obtained genotype data on 3,342 (561 affected) BRCA1 and 1,424 (105 affected) BRCA2 nonoverlapping samples genotyped using the iCOGS array 1,2 .</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Genotype data and Quality Control (QC)</head><p><s>Data from all the genotyping projects apart from the OCAC and CIMBA OncoArray projects have been published previously 1,3-6 .</s><s>Genotypes for OCAC samples were preferentially selected from the different projects in the following order: OncoArray, Mayo GWAS, COGS, and other GWAS.</s></p><p><s>Genotyping was performed at five centers: University of Cambridge, Center for Inherited Disease Research (CIDR), National Cancer Institute (NCI), Genome Quebec and Mayo Clinic.</s><s>OncoArray sample QC was similar to that carried out for the other projects (as described <ref type="bibr" target="#b7">5</ref> ).</s><s>We excluded samples if they had a genotyping call rate &lt; 95%, excessively low or high heterozygosity, if they were not female, or were duplicates (cryptic or intended).</s><s>Duplicates and close relatives were identified using in-house software that calculates a concordance matrix for all individuals.</s><s>Samples with concordance&gt;0.86 were flagged as duplicates and samples with concordance between 0.74 and 0.86 were flagged as relatives.</s><s>The comparison was performed among all the OncoArray samples, and all the previously genotyped samples.</s><s>The concordance statistics were used to identify cryptic duplicates and expected duplicates whose genotypes did not match.</s><s>We attempted to resolve these with the study investigators.</s><s>If the discrepancy could not be resolved both samples were excluded.</s><s>In OCAC, for confirmed cryptic duplicates and relatives, we retained one sample in the analysis.</s><s>For case-control pairs we excluded the control, while for case-case and controlcontrol pairs we excluded the sample with the lower call rate.</s><s>In CIMBA, relatives were included in the analysis and the association tests were adjusted accordingly.</s><s>For confirmed duplicates, the sample with the higher call rate was retained.</s><s>SNP QC was carried out according to the OncoArray QC Guidelines. <ref type="bibr">7</ref></s><s>Only those SNPs that passed QC for all consortia were used for imputation.</s><s>We excluded SNPs with a call rate &lt;95%, SNPs deviating from Hardy-Weinberg equilibrium (P&lt;10 -7 in controls or unrelated samples in CIMBA and P &lt;10 -12 in cases) and SNPs with concordance&lt;98% among 5,280 duplicate pairs.</s><s>For the imputation, we additionally excluded SNPs with a MAF&lt;1% and a call rate &lt;98% and SNPs that could not be linked to the 1000 genomes reference or differed significantly in frequency from the 1000 genomes (European frequency) and a further 1,128 SNPs where the cluster plot was judged to be inadequate.</s><s>Of the 533,631 SNPs which were manufactured on the array, 494,813 SNPs passed the initial QC and 470,825 SNPs were used for imputation.</s><s>Samples with overall heterozygosity &lt;5% or &gt; 40% were excluded.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ancestry analysis</head><p><s>Intercontinental ancestry was calculated for the OCAC samples using the software package FastPop (http://sourceforge.net/projects/fastpop/) 8 developed specifically for the OncoArray.</s><s>Only the samples with &gt;80% European ancestry were used for these analyses.</s><s>For the CIMBA samples 33,661 weakly correlated autosomal SNPs (pair-wise r2 less than 0.1) were used to compute the genomic kinship between all pairs of individuals, along with 267 HapMap samples (CHB, JPT, YRI and CEU).</s><s>These were converted to distances and subjected to multidimensional scaling.</s><s>Using the first two components, we calculated the proportion of European ancestry for each individual and excluded samples with &gt;27% non-European ancestry to ensure that samples of Ashkenazi Jewish ancestry were included in the final sample.</s><s>Analysis using FastPop provided virtually identical results.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Principal components analysis</head><p><s>Principal component analysis for the OncoArray data was carried out using data from 33,661 uncorrelated SNPs (pair-wise r2 less than 0.1) with minor allele frequency greater than 0.05 using an in house program (available at http://ccge.medschl.cam.ac.uk/software/ pccalc/).</s><s>Principal components analysis for the other genotype data sets was carried out as previously described. 1,5</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Imputation</head><p><s>We performed imputation separately for each genotyping project data set.</s><s>We imputed genotypes into the reference panel from the 1000 Genomes Project (v3 October 2014). <ref type="bibr" target="#b11">9</ref></s><s>We initially used an effcient two-step procedure, which involved pre-phasing using SHAPEIT <ref type="bibr">10</ref> followed by imputation of the phased data using IMPUTE2 <ref type="bibr" target="#b13">11</ref> .</s><s>We then performed more accurate imputation for any region with a SNP with P&lt;10 6 in the OCAC analyses or the OCAC/CIMBA meta-analysis.</s><s>The boundaries were set +/â500kb from the most significant SNP in each region.</s><s>The single-step imputation used IMPUTE2 without pre-phasing with some of the default parameters modified.</s><s>These included an increase of the MCMC iterations to 90 (out of which the first 15 were used as burn-in), an increase of the buffer region to 500kb and increasing to 100 the number of haplotypes used as templates when phasing observed genotypes.</s></p><p><s>After imputation, 85 per cent of common variants including both single nucleotide variants and small indels (MAF&gt;0.05)</s><s>have an imputation r 2 imputation accuracy &gt; 0.9 with 97 percent having imputation r 2 &gt; 0.7.</s><s>Of the rare variants (0.001 &lt; MAF &lt; 0.05), 28 per cent have an imputation r 2 &gt; 0.9 and 58 per cent have an imputation r 2 &gt; 0.7.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Association analyses in the unselected ovarian cancer cases and controls from OCAC and CIMBA</head><p><s>We excluded SNPs from the association analysis if their imputation accuracy was r 2 &lt;0.3 or their minor allele frequency (MAF) was &lt;0.01.</s><s>In total, genotypes for 11,595,112 million variants were available for analysis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Association analyses OCAC</head><p><s>We evaluated the association between genotype and disease using the imputed genotype dosage in a logistic regression model.</s><s>We carried out initial, genome-wide analyses separately for OncoArray, COGS and the five GWAS datasets and pooled the results using a fixed effects meta-analysis.</s><s>The analyses were adjusted for study and for population substructure by including the eigenvectors of project-specific principal components as covariates in the model (nine for OncoArray, five for COGS, two for UK GWAS, and two for the US, BWH and POL GWAS, and a single PC for the MAY GWAS).</s><s>The number of eigenvectors chosen was based on the inflection point of a scree plot.</s><s>After one-step imputation of the genotypes in the regions of interest we used genotype dosages in a single logistic regression model with adjustment for each genotyping project/study combination and nineteen principal components.</s><s>Principal components were set to zero for samples not included in a given project.</s><s>We used custom written software for the analysis.</s></p><p><s>EOC is a heterogeneous phenotype with five major histotypes for invasive disease -HGSOC, LGSOC, MOC, ENOC and CCOC -and two histotypes of borderline diseaseserous and mucinous.</s><s>The pattern of association across the different histotypes varies for the known EOC risk loci.</s><s>We therefore carried out the association analysis on the following nine histotypes: all invasive disease; HGSOC; LGSOC; all invasive serous; serous borderline;</s></p><p><s>LGSOC and borderline serous combined; ENOC; CCOC; and mucinous invasive/mucinous borderline combined.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Association analyses CIMBA</head><p><s>We carried out the ovarian cancer association analyses separately for BRCA1 and BRCA2 carriers and for OncoArray and COGS samples.</s><s>The results were pooled using fixed effects meta-analysis.</s><s>The primary analysis was carried out within a survival analysis framework with time to ovarian cancer diagnosis as the endpoint.</s><s>Mutation carriers were followed until the age of ovarian cancer diagnosis, or risk-reducing salpingo-oophorectomy (RRSO) or age at study recruitment.</s></p><p><s>Breast cancer diagnosis was not considered as a censoring event.</s><s>In order to account for the non-random sampling of BRCA1 and BRCA2 carriers with respect to disease status we conducted the analyses by modelling the retrospective likelihood of the observed genotypes conditional on the disease phenotype.</s><s>We assessed the associations between genotype and risk of ovarian cancer using a score test statistic based on the retrospective likelihood. <ref type="bibr" target="#b14">12</ref></s><s>To account for the non-independence among related individuals in the sample, we used an adjusted version of the score test statistic, which uses a kinship-adjusted variance of the score. <ref type="bibr">13</ref></s><s>We evaluated associations between imputed genotypes and ovarian cancer risk using a version of the score test as described above but with the posterior genotype probabilities replacing the genotypes.</s><s>All analyses were stratified by the country of origin of the samples and for Ashkenazi Jewish origin.</s></p><p><s>We carried out the analyses using custom written functions in Fortran and Python.</s><s>The score test statistic was implemented in R version 3.0.1.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>OCAC/CIMBA meta-analysis</head><p><s>We conducted a meta-analysis of the EOC associations in BRCA1, BRCA2 carriers and OCAC samples using an inverse variance approach assuming fixed effects.</s><s>We combined the logarithm of the per-allele hazard ratio estimate for the association with EOC risk in BRCA1 and BRCA2 mutation carriers and the logarithm of the per-allele odds ratio estimate for the association with EOC (any-subtype) and serous EOC in OCAC.</s><s>The number of BRCA1 and BRCA2 samples with tumor histology information was too small to allow for subgroup analyses.</s><s>However, previous studies have demonstrated that the vast majority of EOCs in BRCA1 and BRCA2 mutation carriers are HGSOC.</s><s>Meta-analyses were carried out using the software "metal", 2011-03-25 release <ref type="bibr">14</ref> .</s></p><p><s>We evaluated whether there is evidence for multiple independent association signals in the region around each newly identified locus by evaluating the associations of genetic variants in the region while adjusting for the SNP with the smallest meta-analysis p-value in the respective region.</s><s>This was done separately for BRCA1 carriers, BRCA2 carriers and OCAC.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Candidate causal SNPs in each susceptibility region</head><p><s>In order to identify a set of variants most likely to mediate the observed association -the credible causal variants -we excluded SNPs with causality odds of less than 1:100 by comparing the likelihood of each SNP from the association analysis with the likelihood of the most strongly associated SNP.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Functional annotation of risk associated variants</head><p><s>Expression and methylation quantitative trait loci analyses-A TCGA data set <ref type="bibr">15</ref> was available for 326 HGSOC tumors in women of European ancestry.</s><s>Ancestry was estimated using the Local Ancestry in adMixed Populations (LAMP, <ref type="bibr">16</ref> ) software package and individuals with &gt; 95% European descent were retained for further analyses.</s><s>Matched gene expression (measured on the Agilent 1M microarray), CpG methylation (measured on the Illumina Infinium HumanMethylation27 BeadChip), copy number alteration (called using the Affymetrix SNP 6.0), and germline genotype (called using the Affymetrix SNP 6.0) were also available.</s><s>A Mayo Clinic data set was available for 209 serous EOC tumors and 32 ENOC tumors in women of European ancestry.</s><s>Matched gene expression (measured on the Agilent whole human genome 4x44K expression microarray), CpG methylation (measured on the Illumina Infinium HumanMethylation450), copy number alteration (called using the OncoArray), and germline genotype (called using the OncoArray) were available for all of these samples.</s><s>Genotypes were imputed into the 1000 Genomes October 2014 (Phase 3, version 5) <ref type="bibr" target="#b11">9</ref> European reference panel for both data sets.</s><s>Expression QTL analyses were performed using linear regression as implemented in the R package Matrix eQTL <ref type="bibr">17</ref> .</s><s>Only variants with imputation accuracy R 2 &gt; 0.3 were analyzed.</s><s>Prior to eQTL analyses the effects of tumor copy number and methylation on gene expression were regressed out as previously described <ref type="bibr" target="#b20">18</ref> .</s><s>For the Mayo data set, we performed separate analyses on the HGSOC and ENOC samples.</s><s>Results for the two HGSOC data sets were combined in a random effects meta-analysis.</s><s>We focused on local or cis-acting eQTLs between SNPs in the 1:100 list of potentially causal variants and all genes up to 1 Mb on either side of these SNPs.</s><s>mQTL analyses for the 1:100 potentially causal SNPs in regions of interest (1 MB on either side of the index SNP) were conducted using the Mayo dataset only, because methylation was assayed with the much denser 450K array and the Mayo sample included histologies other than HGSOC.</s><s>Within each region, CpG probes were filtered based on their association with gene expression.</s><s>For each expression probe within the region, a linear model was fit by CpG probe adjusted for age and CNV overlapping the expression probes.</s><s>The CpG with the strongest negative test statistic for each gene (across multiple expression probes per gene) was retained for mQTL analysis in order to reduce the total number of tests.</s><s>We performed VanderWaerden rank transformations of the beta values to account for skewed distributions in the beta-values, and conducted linear regression of the SNP genotypes on the transformed beta values, adjusted for age and CNV overlapping the CpG probe; missing CNV values were imputed using the median for the non-missing samples within each region.</s><s>As a sensitivity analysis, we also performed analyses adjusted only for age.</s><s>Analyses were conducted for all histologies, as well as for the serous, HGSOC, and ENOC subsets.</s><s>Raw.</s><s>Loci were eliminated from analyses where there were either no Agilent probes for the region on the array (9q31.1)</s><s>or there were no negatively associated CpGs on the 450k array (8q21.11).</s></p><p><s>For eQTL and mQTL analyses two-sided p-values are reported.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Mapping risk SNPs to biofeatures</head><p><s>Cell culture-Cell lines were cultured in their respective media as follows: GTFR230, NOSE-CM (1:1 Medium 199: MCDB105 (both Sigma Aldrich), 15% fetal bovine serum (FBS, Hyclone), 500 ng/ml hydrocortisone, 5 Î¼g/ml insulin (both Sigma Aldrich) 10 ng/ml epidermal growth factor and 34 Î¼g protein/ml bovine pituitary extract (both Life Technologies); MCAS, EMEM supplemented with 15% FBS (Seradigm); RMG-II and JHOC5, RPMI plus 10% FBS and OAW42, DMEM containing 10% FBS, 20 Î¼g/ml insulin and sodium pyruvate (Lonza).</s><s>Cell lines were authenticated by profiling short tandem repeats using the Promega Powerplex 16HS Assay (performed at the University of Arizona Genetics Core facility) and all cultures tested negative for contaminating Mycoplasma infections using a Mycoplasma specific PCR.</s></p><p><s>Chromatin immunoprecipitation (ChIP)-Our ChIP protocol was based on the methods of Schmidt et al. <ref type="bibr">19</ref> Four 15cm dishes of cells were fixed in formaldehyde for 10 minutes, before quenching the fixation with glycine.</s><s>Cells were harvested, lysed in a sarkosyl-containing lysis buffer, and sonicated using the Covaris E220 evolution Focused-Ultrasonicator to yield 100-300bp genomic DNA fragments.</s><s>5 Î¼g of an antibody raised against H3K27ac (Diagenode) was incubated with blocked magnetic Dynabeads (Life Technologies) at 4Â°C for 4 hours.</s><s>Antibody-bead conjugates were incubated with 100 Î¼g chromatin at 4Â°C overnight, with constant agitation.</s><s>Beads were washed extensively with RIPA buffer and then RNase and proteinase K (both Qiagen) treated.</s><s>DNA was then eluted from the beads in TE buffer and cleaned up using the QIAquick PCR Purification kit (Qiagen).</s><s>Two independent immunoprecipitations and one input sample were sequenced for each cell line and each sample was quality checked by site-specific qPCR prior to next generation sequencing (NGS).</s></p><p><s>Next generation sequencing-ChIP libraries were constructed using the Kapa Hyper Library Preparation kit, according to manufacturer's instructions.</s><s>Approximately 2/3 of the immunoprecipitated (IP) material was used as the starting amount.</s><s>For undiluted input samples, 100-300 ng of starting material was used.</s><s>Construction was carried out according to manufacturer's instructions using Bio NextFLex adapters diluted 1:50.</s><s>Final PCR on a portion of the adapter ligation was performed for 12 cycles.</s><s>Products were evaluated by the Agilent Bioanalyzer, using high sensitivity DNA chips.</s><s>ChIP libraries were quantified using Kapa Biosystems Illumina library quantification kit, then 12 pooled for sequencing, which was carried out using single end reads with 75 cycles on a NextSeq 500 (with version 2 chemistry).</s></p><p><s>Analysis of ChIP-seq data-ChIP-seq data were processed using MACS2 with p value cutoff of 0.001.</s><s>The smaller of input or signal was linearly scaled to the same depth as the larger dataset.</s><s>In order to control the irreproducible discovery rate in ChIPseq analysis, we used IDR version 2.0 pipeline. <ref type="bibr">20</ref></s><s>A standard IDR threshold p&lt; 0.05 was applied.</s></p><p><s>Functional annotation of variants-We used shell scripts with bedtools (http:// bedtools.readthedocs.org/en/latest/)</s><s>to generate overlap data between all variants in each associated region including likely causal SNPs and bed file versions of all the data represented in Figure <ref type="figure">2</ref> and Supplementary Table <ref type="table">6</ref>.</s><s>In addition we included 3'UTRs, 5'UTRs, miRcode high confidence conserved microRNA target sites, high confidence microRNA target sites from microRNA.org,</s><s>and all coding exons.</s><s>The overlap data thus obtained were converted to matrix form by means of python scripts.</s><s>MicroRNA target sites were only considered that overlapped untranslated (UTR) gene regions.</s><s>Exonic variants were further assessed for missense or nonsense mutations by Mutect software <ref type="bibr">21</ref> .</s><s>The NHGRI-EBI GWAS catalog was used to identify SNPs among the potentially causal set with other genome-wide signification associations (Supplementary table <ref type="table" target="#tab_0">14</ref>).</s></p><p><s>Locus-specific tissue enrichment of variants-H3K27 acetylation peaks were collated from public sources (for HeLa-S3, HCT116, UCSD Ovary, UCSD Sigmoid Colon, Colon Crypt) or from in-house data (IOSE4, IOSE11, FT33, FT246, EEC16, CaOV3, UWB1.289,</s><s>OAW42, GFTR230, MCAS) (Supplementary table 5 and Supplementary table <ref type="table" target="#tab_0">16</ref>).</s><s>Overlaps were counted for the all SNPs against which genotypes were imputed in 1000 genomes for each H3K27Ac dataset.</s><s>The fraction of causal SNPs with overlaps was then tested for significance against this background for each cell type in the H3K27ac datasets using the hypergeometric distribution.</s><s>Finally, p values were adjusted for multiple comparisons using Bonferroni's method.</s><s>The forest plot shows the point estimates of odds ratios with 95% confidence intervals around each estimate.</s><s>Odds ratios and confidence intervals in bold are histotypes significant at nominal P&lt;0.05.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Figure 2. Number of overlaps between causal SNPs and H3K27ac in relevant tissues and cell lines</head><p><s>Height of each bar in the histogram represents the number of candidate causal SNPs at each locus overlapping H3K27ac marks in a particular cell line.</s><s>Loci are grouped according to their association with different histotypes of ovarian cancer.</s><s>The number of causal SNPs at 100:1 odds relative to the top regional SNP is indicated by the red circles (scale below, right).</s><s>In the key cell lines are grouped according to their likely relevance to the different histotypes.</s><s>Abbreviations: mucinous ovarian cancer (MOC), low grade serous ovarian cancer   From analysis of imputed genotyped derived from one-step imputation (see methods); c test for heterogeneity of effect between study strata in OCAC; RAF, risk allele frequency; LCL, lower 95% confidence limit; UCL, upper 95% confidence limit; LG, low grade; HG, high grade; position is genome build 37; BFRP Bayes false positive reporting probability assuming prior of 1:10,000</s></p><p><s>Nat Genet.</s><s>Author manuscript; available in PMC 2017 November 01.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>Histotype specific associations (odds ratios) of top SNP in 12 novel EOC susceptibility regions</s></p></div></figDesc><graphic coords="32,181.20,62.00,309.60,504.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 3 .</head><label>3</label><figDesc><div><p><s>Figure 3. Functional analysis of the chr10q24.33</s><s>locus (a) Active chromatin, denoted by H3K27ac signaling, in EOC-relevant cell types.</s><s>(b) Regional association plot for genotyped and imputed SNPs.</s><s>The dashed box highlights the region shown in panel (a) (c) MotifbreakR analysis, a non-canonical CTCF motif is significantly altered by SNP rs2488000.</s><s>(d) EQTL analysis, OBFC1 expression is associated with rs11597399 genotype in HGSOCs from TCGA.</s><s>Box and whisker plot showing median (horizontal line within box), interquartile range (IQR; length of box) and 1.5 times the IQR (whiskers) of OBFC1 expression for each genotype.</s></p></div></figDesc><graphic coords="35,84.00,62.00,504.00,272.16" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc><div><p><s>across the six data sets; b</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="33,157.44,62.00,357.12,504.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p><s>New genome-wide significant epithelial ovarian cancer susceptibility loci</s></p></div></figDesc><table><row><cell>BFRP</cell><cell></cell><cell>&lt;1%</cell><cell>6%</cell><cell>7%</cell><cell>5%</cell><cell>3%</cell><cell>11%</cell><cell>7%</cell><cell>3%</cell><cell></cell></row><row><cell>P-het c</cell><cell></cell><cell>0.88</cell><cell>0.61</cell><cell>0.52</cell><cell>0.79</cell><cell>0.38</cell><cell>0.56</cell><cell>0.99</cell><cell>0.087</cell><cell></cell></row><row><cell>P-value b</cell><cell></cell><cell>1.5 Ã 10 -13</cell><cell>4.5 Ã 10 -8</cell><cell>4.7 Ã 10 -8</cell><cell>4.5 Ã 10 -8</cell><cell>2.0 Ã 10 -9</cell><cell>1.7 Ã 10 -8</cell><cell>4.0 Ã 10 -8</cell><cell>3.9 Ã 10 -8</cell><cell></cell></row><row><cell>Risk Allele RAF r 2a OR LCL UCL</cell><cell></cell><cell>G:GCCAG 1.20 1.37 0.33 0.86 1.29</cell><cell>G:A 1.12 1.27 0.73 0.97 1.19</cell><cell>G:T 1.14 1.32 0.56 0.86 1.23</cell><cell>GTGACAC 1.11 1.26 0.56 0.86 1.18</cell><cell>C:T 1.65 2.90 0.99 0.77 2.19</cell><cell>C:A 1.18 1.41 0.88 0.98 1.29</cell><cell>C:T 1.18 1.41 0.12 0.94 1.29</cell><cell>G:A 1.12 1.27 0.31 0.98 1.19</cell><cell>T:C 0.91 0.99 1.17</cell></row><row><cell>Chr Position</cell><cell></cell><cell>3q22.3 138,849,110</cell><cell>3q28 190,525,516</cell><cell>4q32.3 167,187,046</cell><cell>5q12.3 66,121,089</cell><cell>8q21.11 77,320,354</cell><cell>9q31.1 104,943,226</cell><cell>10q24.33 105,694,301</cell><cell>18q11.2 21,405,553</cell><cell>22q12.1 28,934,313</cell></row><row><cell>Histotype</cell><cell></cell><cell>Mucinous: invasive + borderline</cell><cell>Serous: LG + borderline</cell><cell>Serous: borderline</cell><cell>Endometrioid</cell><cell>Serous: LG + borderline</cell><cell>Mucinous: invasive + borderline</cell><cell>Serous: LG + borderline</cell><cell>Serous: LG + borderline</cell><cell>Serous: invasive</cell></row><row><cell>SNP</cell><cell>OCAC analyses</cell><cell>rs112071820</cell><cell>rs9870207</cell><cell>rs13113999</cell><cell>rs555025179</cell><cell>rs150293538</cell><cell>rs320203</cell><cell>rs7902587</cell><cell>rs8098244</cell><cell>rs6005807</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Nat Genet. Author manuscript; available in PMC 2017 November 01.</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>The OCAC Oncoarray genotyping project was funded through grants from the U.S. National Institutes of Health We pay special tribute to the contribution of Professor Brian Henderson to the GAME-ON consortium and to Olga M. Sinilnikova for her contribution to CIMBA and for her part in the initiation and coordination of GEMO until she sadly passed away on the 30th June 2014.</s><s>We thank the study participants, doctors, nurses, clinical and scientific</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data availability</head><p><s>OncoArray germline genotype data for OCAC studies will be available through dbGap (www.ncbi.nlm.nih.gov/gap).</s><s>Summary results are available from the Ovarian Cancer Association Consortium (http://ocac.ccge.medschl.cam.ac.uk/).</s><s>A subset of the OncoArray germline genotype data for the CIMBA studies will be made publically available through dbGAP.</s><s>The complete dataset will not be made publically available due to restraints imposed by the ethics committees of individual studies; requests for further data can be made to the Data Access Coordination Committee (http://cimba.ccge.medschl.cam.ac.uk/).</s><s>ChipSeq data are available from the Gene Expression Omnibus (www.ncbi.nlm.nih.gov/</s><s>geo), GEO accession number GSE68104.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supplementary Material</head><p><s>Refer to Web version on PubMed Central for supplementary material.</s><s>collaborators, health care providers and health information sources who have contributed to the many studies contributing to this manuscript.</s><s>A full list is provided in the Supplementary Notes.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Trinidad Caldes 59 , Maria A. Caligo 60 , Ian Campbell 61,62 , Rikki Cannioto 63 , Michael E. Carney 64 , Terence Cescon 43 , Salina B. Chan 65 , Jenny Chang-Claude 66,67 , Stephen Chanock 42 , Xiao Qing Chen 11 , Yoke-Eng Chiew 68</title>
	</analytic>
	<monogr>
		<title level="m">Marina Bermisheva 37 , Marcus Q. Bernardini 38 , Michael J. Birrer 39 , Line Bjorge 40</title>
		<title level="s">Peter A. Fasching</title>
		<editor>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Frans</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Helene</forename><surname>Hogervorst</surname></persName>
		</editor>
		<editor>
			<persName><surname>Holland 11</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">J</forename><surname>Maartje</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Karen</forename><surname>Hooning</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Ruea-Yea</forename><surname>Hosking 4</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Peter</forename><forename type="middle">J</forename><surname>Huang 139</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Jillian</forename><surname>Hulick</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">David</forename><forename type="middle">J</forename><surname>Hung</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">David</forename><forename type="middle">G</forename><surname>Hunter</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Tomasz</forename><surname>Huntsman</surname></persName>
		</editor>
		<editor>
			<persName><surname>Huzarski 123</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">N</forename><surname>Evgeny</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Claudine</forename><surname>Imyanitov</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Edwin</forename><forename type="middle">S</forename><surname>Isaacs 144</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Louise</forename><surname>Iversen 145</surname></persName>
		</editor>
		<editor>
			<persName><surname>Izatt 146</surname></persName>
		</editor>
		<meeting><address><addrLine>Norbert Arnold; Rosa B; Louise Brinton; Bernd Dworniczak 93 , Diana Eccles; Steve Ellis; Kevin H. Eng; Sarah Ferguson; Zachary C. Fogarty 6 , RenÃ©e; Brooke L. Fridley; MarÃ­a J. GarcÃ­a; Graham G. Giles; Uffe Birk Jensen; Sharon Johnatty 11 , Michael E. Jones; Melissa C. Larson; Shashikant B. Lele; Karen H. Lu</addrLine></address></meeting>
		<imprint>
			<publisher>Allan Jensen</publisher>
			<date>Jocelyne Chiquette 70. Jan Hauke 125. Jan LubiÅski 123. Taymaa May 38</date>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page">165</biblScope>
		</imprint>
	</monogr>
	<note>Alfons Meindl. Usha Menon 113 , Arjen R. Mensenkamp 187 , Melissa A. Merritt 188 , Roger L</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Olufunmilayo I. Olopade</title>
		<editor>Milne 54,115 , Gillian Mitchell 147</editor>
		<imprint>
			<biblScope unit="volume">189</biblScope>
			<biblScope unit="page">203</biblScope>
			<date>Francesmary Modugno 190,191,192. 193. Marco Montagna 195. 196. Jacob Musinsky 198. 200. Dieter Niederacher 201</date>
		</imprint>
	</monogr>
	<note>Katherine L. Nathanson. HÃ¥kan Olsson 52,205 , Curtis Olswold 175 , David M</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Porteous 222 , Fabienne Prieur 223 , Darya Prokofyeva 79 , Elizabeth Pugh 17 , Miquel Angel Pujana 224 , Pascal Pujol 225 , Paolo Radice 226</title>
	</analytic>
	<monogr>
		<title level="m">Tanja Pejovic 193,194 , Liisa M. Pelttari 155 , Jennifer B. Permuth 8 , Paolo Peterlongo 216</title>
				<editor>
			<persName><forename type="first">Kathryn</forename><forename type="middle">L</forename><surname>Terry</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Pamela</forename><forename type="middle">J</forename><surname>Thompson 256</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Liv Cecilie Vestrheim</forename><surname>Thomsen</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Darcy</forename><forename type="middle">L</forename><surname>Thull</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Laima</forename><surname>Tihomirova 258</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Anna</forename><forename type="middle">V</forename><surname>Tinker 259</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Marc</forename><surname>Tischkowitz 105</surname></persName>
		</editor>
		<meeting><address><addrLine>Malcolm C. Pike; Honglin Song 4 , Melissa C. Southey 245 , Amanda B. Spurdle; Alicia Tone; Britton Trabert 42 , Ruth C. Travis; David; Alice S</addrLine></address></meeting>
		<imprint>
			<date>Marion Piedmonte 219. Silvia Tognazzo 195</date>
			<biblScope unit="volume">208</biblScope>
			<biblScope unit="page">255</biblScope>
		</imprint>
	</monogr>
	<note type="report_type">Muy-Kheng Tea 217</note>
	<note>Nicolas Wentzensen</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Rita Katharina Schmutzler</title>
		<editor>Â§ , Ellen L. Goode 9, Â§ , Thomas A. Sellers 8, Â§ , Simon A. Gayther 10, Â§ , Antonis C. Antoniou 3,4, Â§ , and Paul D.P.</editor>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="237" to="249" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>Virchows Arch. PubMed: 22322322</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Fallopian tube precursors of ovarian low-and high-grade serous neoplasms</title>
		<author>
			<persName><forename type="first">R</forename><surname>Vang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Shih Ie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Kurman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Histopathology</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="44" to="58" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23240669</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Tubal origin of ovarian endometriosis and clear cell and endometrioid carcinoma</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Cancer Res</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="869" to="879" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 26045974</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Molecular pathogenesis of ovarian clear cell carcinoma</title>
		<author>
			<persName><forename type="first">I</forename><surname>Gounaris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Brenton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Future Oncol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="1389" to="1405" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 25952785</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Mucinous tumors of the ovary: current thoughts on diagnosis and management</title>
		<author>
			<persName><forename type="first">J</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Frumovitz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Oncol Rep</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page">389</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 24777667</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Ovarian cancer familial relative risks by tumour subtypes and by known ovarian cancer genetic susceptibility variants</title>
		<author>
			<persName><forename type="first">S</forename><surname>Jervis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Med Genet</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="108" to="113" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 24277755</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Most common &apos;sporadic&apos; cancers have a significant germline genetic component</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Lu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Mol Genet</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="6112" to="6118" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 24943595</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2</title>
		<author>
			<persName><forename type="first">H</forename><surname>Song</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="996" to="1000" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19648919</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Goode</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="874" to="879" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20852632</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Common variants at 19p13 are associated with susceptibility to ovarian cancer</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Bolton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page">20852633</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31</title>
		<author>
			<persName><forename type="first">J</forename><surname>Permuth-Wey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Commun</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">1627</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23535648</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer</title>
		<author>
			<persName><forename type="first">H</forename><surname>Shen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Commun</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">1628</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23535649</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Bojesen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="371" to="384" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23535731</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Pharoah</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="362" to="370" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23535730</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Identification of six new susceptibility loci for invasive epithelial ovarian cancer</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Kuchenbaecker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="164" to="171" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 25581431</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Genome-wide significant risk associations for mucinous ovarian carcinoma</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Kelemen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="888" to="897" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 26075790</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Kar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Discov</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="1052" to="1067" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>PubMed: 27432226</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">The OncoArray Consortium: a Network for Understanding the Genetic Architecture of Common Cancers</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">I</forename><surname>Amos</surname></persName>
		</author>
		<idno type="DOI">10.1158/1055-9965.EPI-16-0106</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Epidemiol Biomarkers Prev</title>
		<imprint>
			<date type="published" when="2016-10-03">2016. Oct 3. 2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Couch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Genet</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">e1003212</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23544013</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">The 1000 Genomes Project. An integrated map of genetic variation from 1,092 human genomes</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Abecasis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">491</biblScope>
			<biblScope unit="page" from="56" to="65" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 23128226</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer</title>
		<author>
			<persName><forename type="first">K</forename><surname>Lawrenson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Carcinogenesis</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="1341" to="1353" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 26424751</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Evaluation of association methods for analysing modifiers of disease risk in carriers of high-risk mutations</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Barnes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Easton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Antoniou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genet Epidemiol</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="274" to="291" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22714938</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Patterns of cis regulatory variation in diverse human populations</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">E</forename><surname>Stranger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Genet</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e1002639</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22532805</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Integrative eQTL-based analyses reveal the biology of breast cancer risk loci</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">152</biblScope>
			<biblScope unit="page" from="633" to="641" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23374354</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">motifbreakR: an R/Bioconductor package for predicting variant effects at transcription factor binding sites</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Coetzee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Coetzee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Hazelett</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="3847" to="3849" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 26272984</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Guan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="5745" to="5755" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>PubMed: 17908964</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">The NHGRI GWAS Catalog, a curated resource of SNP-trait associations</title>
		<author>
			<persName><forename type="first">D</forename><surname>Welter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="D1001" to="1006" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 24316577</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">A Bayesian measure of the probability of false discovery in genetic epidemiology studies</title>
		<author>
			<persName><forename type="first">J</forename><surname>Wakefield</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Hum Genet</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="208" to="227" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note>PubMed: 17668372</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects</title>
		<author>
			<persName><forename type="first">S</forename><surname>Jervis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Med Genet</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="465" to="475" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 26025000</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Coetzee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Mol Genet</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="3595" to="3607" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 25804953</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Kurman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Surg Pathol</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="1605" to="1614" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21997682</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Ovarian low-grade serous carcinoma: a comprehensive update</title>
		<author>
			<persName><forename type="first">I</forename><surname>Diaz-Padilla</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gynecol Oncol</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="page" from="279" to="285" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22555104</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">OB fold-containing protein 1 (OBFC1), a human homolog of yeast Stn1, associates with TPP1 and is implicated in telomere length regulation</title>
		<author>
			<persName><forename type="first">M</forename><surname>Wan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Qin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Songyang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">284</biblScope>
			<biblScope unit="page" from="26725" to="26731" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19648609</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Telomere length in different histologic types of ovarian carcinoma with emphasis on clear cell carcinoma</title>
		<author>
			<persName><forename type="first">E</forename><surname>Kuhn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mod Pathol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="1139" to="1145" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21499239</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">CAUSEL: an epigenome-and genome-editing pipeline for establishing function of noncoding GWAS variants</title>
		<author>
			<persName><forename type="first">S</forename><surname>Spisak</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="1357" to="1363" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 26398868</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus</title>
		<author>
			<persName><forename type="first">K</forename><surname>Lawrenson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Commun</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">12675</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>PubMed: 27601076</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Shared genetics underlying epidemiological association between endometriosis and ovarian cancer</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Lu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Mol Genet</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="5955" to="5964" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 26231222</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Molecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypes</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Jonsson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">e107643</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>PubMed: 25226589</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Gaudet</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Genet</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">e1003173</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23544012</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">The OncoArray Consortium: a Network for Understanding the Genetic Architecture of Common Cancers</title>
		<author>
			<persName><forename type="first">C</forename><surname>Amos</surname></persName>
		</author>
		<author>
			<persName><surname>Dj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Byun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Schumacher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Epidemiol Biomarkers Prev</title>
		<imprint>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">FastPop: a rapid principal component derived method to infer intercontinental ancestry using genetic data</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page">122</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>PubMed: 26961892</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Shape-IT: new rapid and accurate algorithm for haplotype inference</title>
		<author>
			<persName><forename type="first">O</forename><surname>Delaneau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Coulonges</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Zagury</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">540</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 19087329</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Population-specific genotype imputations using minimac or IMPUTE2</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Leeuwen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Protoc</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="1285" to="1296" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>PubMed: 26226460</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Antoniou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="885" to="892" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20852631</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">METAL: fast and efficient meta-analysis of genomewide association scans</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Willer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Abecasis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="2190" to="2191" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>PubMed: 20616382</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">The Cancer Genome Atlas: Integrated genomic analyses of ovarian carcinoma</title>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">474</biblScope>
			<biblScope unit="page" from="609" to="615" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>PubMed: 21720365</note>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Estimating local ancestry in admixed populations</title>
		<author>
			<persName><forename type="first">S</forename><surname>Sankararaman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sridhar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kimmel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Halperin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Hum Genet</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="290" to="303" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>PubMed: 18252211</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Matrix eQTL: ultra fast eQTL analysis via large matrix operations</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Shabalin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="1353" to="1358" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>PubMed: 22492648</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">ChIP-seq: using high-throughput sequencing to discover protein-DNA interactions</title>
		<author>
			<persName><forename type="first">D</forename><surname>Schmidt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Methods</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="240" to="248" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19275939</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">An overview of recent developments in genomics and associated statistical methods</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Bickel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Philos Trans A Math Phys Eng Sci</title>
		<imprint>
			<biblScope unit="volume">367</biblScope>
			<biblScope unit="page" from="4313" to="4337" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>PubMed: 19805447</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples</title>
		<author>
			<persName><forename type="first">K</forename><surname>Cibulskis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Biotechnol</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="213" to="219" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>PubMed: 23396013</note>
</biblStruct>

<biblStruct xml:id="b54">
	<monogr>
		<title level="m" type="main">high grade serous ovarian cancer (HGSOC), and epithelial ovarian cancer (EOC) precursors</title>
		<imprint/>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
